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ABSTRACT OF THE DISSERTATION 
Heart-focused Anxiety and Cardiac Treatment Adherence 
 
by 
 
Angelyna M. Lowe 
 
Doctor of Philosophy, Graduate Program in Clinical Psychology  
Loma Linda University, September 2016 
Dr. Holly E. R. Morrell, Chairperson 
 
 
Cardiac disease is the leading cause of death and functional impairment in North 
America. Treatment adherence in general is a major obstacle for the cardiac population. 
Anxiety is a potential barrier to treatment adherence, yet results of previous studies are 
equivocal, possibly due to anxiety being measured too generally. Heart-focused anxiety 
was measured in the current study to determine if it is a better predictor of treatment 
adherence than general anxiety, after controlling for other known predictors of adherence. 
Sixty-five participants between 29 and 96 years of age (M = 69.24, SD = 14.18; 56.9% 
female) were recruited from the Loma Linda University Medical Center. Participants 
were given a questionnaire to complete, either by mail or online, in which demographic 
characteristics, treatment adherence, general anxiety, heart-focused anxiety, and other 
known predictors of treatment adherence were measured. Two hierarchical multiple 
linear regression models were run to test whether the subscales of heart-focused anxiety 
predicted lifestyle and medication adherence, respectively, above and beyond the 
influence of demographic variables, other known predictors, and general anxiety. Three 
hierarchical binomial logistic regression models were run to test whether heart-focused 
anxiety predicted healthy LDL, HDL and blood pressure levels above and beyond the 
influence of demographic variables, other known predictors, and general anxiety. None of 
xi 
the CAQ subscales significantly predicted adherence, but effect sizes were large enough 
to warrant interpretation. In general, fear-related anxiety increased odds of non-
adherence, while avoidance and attention produced mixed results. Knowledge and 
positive coping significantly predicted lifestyle recommendation adherence, gender 
(being male) and positive coping significantly predicted unhealthy LDL cholesterol 
levels, and being unmarried significantly predicted lower blood pressure. Results suggest 
that patients with more fear-related anxiety are more likely to be non-adherent to 
recommended treatments. In general, the CAQ subscales were stronger predictors of 
treatment adherence than general anxiety, indicating that they may be better determinants 
of treatment adherence than general anxiety alone. Results also indicated that those with 
more knowledge and who use positive coping are more likely to be adherent to lifestyle 
recommendations, men and those with less positive coping skills are more likely to have 
high LDL cholesterol, and unmarried individuals are less likely to have high blood 
pressure. Targeting these individuals to offer specific interventions may improve 
treatment adherence through increased education, patient-physician communication, and 
psychological interventions aimed at reducing fear and anxiety.  
 
 
1 
CHAPTER ONE 
INTRODUCTION 
 
Coronary Artery Disease 
Every year since 1900, except 1918, coronary artery disease (CAD) has been the 
leading cause of death in North America (Go et al., 2013). As of 2009 in the United 
States, one person dies of cardiovascular disease every 40 seconds, which amounts to 
over 2150 deaths per day (Go et al., 2013). While this is a 32.7% decline from 1998, 
CAD remains a significant burden. Each year, an estimated 785,000 Americans will have 
a new heart attack (Roger et al., 2011). Of the 45 million individuals with functional 
disabilities, CAD is among the top 15 causes of those disabilities (Roger et al., 2011). 
Coronary artery disease in the United States is associated with more health care costs 
than another other disease, costing over an estimated $297 billion (Roger et al., 2011). 
This estimate includes medications, doctor visits, hospital services, physician services, as 
well as indirect costs such as lost productivity due to death.  
Coronary artery disease also has serious psychosocial implications. Psychosocial 
factors, such as depression and anxiety, are among the nine modifiable risk factors that 
account for 90% of heart attacks worldwide (Gehi, 2005). Research shows that 15-20% 
of cardiac patients meet criteria for Major Depressive Disorder (Kent, 2009). Evidence 
also suggests that anxiety is a significant independent risk factor for cardiovascular 
disease and coronary heart disease (McCann et al., 2005; Roest, 2010). According to the 
World Health Organization (2004), anxiety disorders are the most prevalent in the world. 
However, little research exists on anxiety’s direct role in CAD and its treatment. 
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Identifying and modifying psychosocial risk factors such as anxiety is an important step 
in reducing the occurrence of cardiac related events.  
 
Recommended Lifestyle Changes/Treatments 
While specific treatments vary, in general there are common recommended 
lifestyle changes and treatments for the cardiac population. Cardiac patients are 
encouraged to adhere to a healthier, reduced salt, Mediterranean-style diet because it has 
been shown to reduce mortality by 65-73% (Roger et al., 2011). It is suggested that 
patients engage in 150 minutes of vigorous activity a week, which is shown to reduce 
mortality by 27% in cardiac patients (Go et al., 2013; Roger et al., 2011). Patients are 
also expected to adhere to medical treatments, including surgical treatments and, more 
commonly, medication regimens, yet over 60% of this population has been reportedly 
non-adherent to medication, significantly increasing their risk for a cardiac event 
(Kravitz, 1993).  
One of the most strongly recommended treatments for patients with CAD is 
cardiac rehabilitation. Cardiac rehabilitation is a three-month treatment program that 
consists of patient assessment, nutritional counseling, risk management, psychosocial 
interventions, and physical intervention and counseling (Balady, 2007). Patients usually 
attend rehabilitation following a cardiac event to strengthen their heart and encourage a 
new healthier lifestyle. Patients attend the program three to five days a week, and their 
medical and psychosocial progress is monitored throughout treatment. Cardiac 
rehabilitation has been shown to account for a 24% reduction of all-cause mortality and a 
25% reduction in cardiovascular mortality (Oldridge, 1988). Significant improvements 
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following a cardiac rehabilitation program in exercise capacity, BMI, obesity indexes, 
and lipid levels have also been observed, in which exercise capacity showed a 34% 
increase, while body fat decreased by 6% overall (Lavie et al., 1993). Despite these 
benefits, only about one-third of patients attend rehabilitation following a cardiac event 
(Daly, 2002). 
 
Adherence 
Non-adherence to cardiac treatment plans leads to worse outcomes for cardiac 
patients (Gehi, 2005). Adherence is defined as the extent to which a person’s behaviors 
align with medical recommendations for treatment that are agreed upon by both physician 
and patient (Horowitz, 1993). Even outcomes of adherence to a placebo treatment have 
been shown to be better than non-adherence (Horowitz, 1993). Non-adherence occurs 
when a patient forgets to take medication, refuses dietary changes, does not follow a 
prescribed exercise regimen, or engages in other behaviors inconsistent with physician 
recommendations (DiMatteo, 2000). These behaviors are directly related to adverse 
health outcomes (DiMatteo, 2000; Gehi, 2005). Adherence has a strong behavioral 
component and is largely in the hands of the patient, as evidenced by the fact that the 
very definition of adherence includes reliance on the patient’s behavior (Horowitz, 1993).  
Traditionally, medical professionals speak in terms of whether or not a patient is 
compliant with their prescribed treatment. Compliance to treatment generally has a 
negative connotation, as medical non-compliance is defined as the refusal to comply with 
treatment recommendations (Vermeire et al., 2001). This definition implies that patients 
are only in line with their medical treatment if they accept and agree to the terms their 
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physicians prescribe. Much of the research on compliance focuses on how often the 
patient obeys his or her physician, and ignores the role of decision-making on the part of 
the patient. More recently, adherence has become the preferred term because of its 
emphasis on the patient’s involvement in his or her care (Vermeire et al., 2001). This 
term removes the paternal role of the physician and creates a sense of partnership 
between the doctor and patient. In order for this type of relationship to work, patients 
must be active participants in their health care and behave in a way that moves them 
toward their health goals.     
 Currently, adherence in the cardiac population is measured in a variety of ways. A 
higher number of cancelled or no-show appointments are indicative of non-adherence 
(Morisky, 2008). When in the healthy normal range (systolic pressure at or below 140 
mm Hg and diastolic pressure at or below 90 mm Hg), blood pressure indicates that 
patients are compliant with their treatment (Morisky, 2008). Abnormal lipid levels, 
specifically cholesterol, are a risk factor for a myocardial infarction; therefore, when 
within normal limits, lipid levels can indicate adherence to medication (Yusuf et al., 
2004). Cholesterol is commonly assessed with two values, low-density lipid cholesterol 
(LDL) and high-density lipid cholesterol (HDL). LDL cholesterol is known as the “bad” 
cholesterol, and contributes to plaque build-up in arteries. HDL is known as the “good” 
cholesterol and removes the LDL from the arteries, and protects the heart against heart 
attacks and stroke (AHA, 2014). Lastly, measuring medication-taking behaviors through 
self-report measures is used to determine a patient’s adherence to treatment (Morisky, 
2008). Self-report measures have been shown to provide the most accurate information 
when assessing medication adherence, above and beyond clinical interviews (Garber et 
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al., 2004). Adherence to diet and exercise is generally assessed by asking patients to 
recall their most recent behaviors and determining if they are in accordance with the 
American Heart Association’s recommendations (Chiuve et al., 2011; Lichtenstein et al., 
2006).    
 As previously mentioned, CAD is one of the leading causes of death, yet has nine 
identified modifiable risk factors (Roger et al., 2011). This indicates that many of the risk 
factors that contribute to CAD can be reduced through active patient participation in 
treatment. Not only would individual patient health improve with increased adherence, 
but overall health care cost and use of resources have the potential to be substantially 
reduced if fewer resources are utilized. However, adherence to treatment is often low in 
this population.  
 For cardiac patients, adherence to various aspects of treatments is typically very 
poor. In 2005, fewer than 20% of adults who were being treated for coronary heart 
disease were at their low-density lipoprotein goals, indicating a lack of adherence to their 
treatment regimens (Roger et al., 2011). Adherence to dietary restrictions is also usually 
poor, as the American Heart Association reports that only 19% of hypertensive adults 
between 1994 and 2000 were adherent to diet recommendations (Roger et al., 2011). 
Lastly, the American Heart Association also reported that 64.5% of cardiac patients do 
not engage in any moderate or vigorous physical activity (Go et al., 2013). 
Not adhering to medical treatments leads to poorer clinical outcomes, re-
hospitalizations, and increased mortality overall (Baroletti, 2010). In a review of 
literature regarding non-adherence and non-compliance in heart failure patients, non-
adherence to medication and diet was the most commonly cited cause of worsening heart 
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failure (van der Wal, 2005). In 21-64% of patients, non-adherence was the largest factor 
for worsening heart failure and hospitalizations. Research also indicates that patients who 
fill only some or none of their discharge prescriptions have 44-80% higher mortality rates 
at one-year follow-up (Jackevicius et al., 2008).  Another study found that patients who 
were non-compliant with their medication regimens had higher readmission rates, more 
hospitalization days and lower ejection fractions at a six-year follow-up than those who 
were compliant (Miura et al., 2001).  
 
Factors that Influence Adherence 
Gender 
In general, women are more likely to utilize both preventative and treatment 
health care resources (Pinkhasov et al., 2010), However, research on gender and 
adherence in the cardiac population has produced variable results depending on the type 
of treatment being evaluated. In a study that assessed adherence to a sodium-restricted 
diet in heart failure patients, women were significantly more adherent to the 
recommendations, as evidenced by a urine sample (Chung et al., 2006). In this particular 
study, women were more knowledgeable of the effects of sodium, which may account for 
their increased adherence. In contrast, another study assessing patient adherence to 
antihypertensive medication at diagnosis and at a six month follow-up found that there 
were significantly more women in the low adherence group at baseline, and that women 
were less likely to be in the high adherence category following the study (Mazzaglia et 
al., 2009). Men are also far more likely to attend cardiac rehabilitation than women, as 
women only represent 20% of the rehabilitation population (Allen, 2004; Daly, 2002; 
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Grace, 2002). However, this finding is largely impacted by the fact that men are more 
likely to receive referrals to cardiac rehabilitation and are more likely to attend because 
they are typically younger and healthier at the time of onset (Grace, 2002; Roger, 2011). 
A recent study examining 500 physicians’ knowledge and attitudes regarding gender and 
cardiovascular disease revealed that less than 20% of physicians were aware that more 
women die from CVD each year than men (Mosca et al., 2014). These physicians were 
then less likely to recommended appropriate treatments to women because of the 
perceived lower risk.  
 
Age 
Most studies seem to indicate that older age may be associated with poorer 
adherence. Chapman et al. (2005) found that age is a significant predictor of medication 
adherence, with those ages 55-64 being the most adherent, followed by ages 65-74 
(Chapman et al., 2005). In a study examining patient adherence to antihypertensive 
medication, older age was associated with a decreased likelihood of being a high adherer 
to medication six months following a cardiac diagnosis (Mazzaglia et al., 2009). For 
long-term adherence to secondary treatments, including aspirin, beta-blockers, and lipid-
lowering agents, and a combination of these therapies, older age was consistently 
associated with an 8-23% decrease in adherence to recommended treatments (Newby et 
al., 2006).  The American Heart Association found adherence to physical activity 
recommendations decreased with age from 55.8% in adults 18-44 years old to 27.4% for 
those over 75 years of age (Go et al., 2013). Furthermore, old age has also been identified 
as a barrier to participation in cardiac rehabilitation (Jackson et al., 2004).  
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The negative relationship between age and adherence may be due to several 
things. It is possible that those older in age may find it more difficult to implement the 
substantial lifestyle changes that are asked of heart patients, such as increasing exercise 
and changing their diet. Adherence in older age may also be affected by social support, as 
more assistance from family members or friends may be necessary to follow through with 
treatment recommendations such as diet change, medication reminders, or transportation 
to appointments. Given that age may affect adherence, it is an important variable to 
include in any study examining adherence to cardiac treatment. 
 
Social Support 
In general, higher levels of social support facilitate healthy behaviors and increase 
adherence to medical treatment recommendations (Uchino, 2007). For the cardiac 
community, it has been found that higher levels of social support are associated with 
reduced mortality and there is increasing evidence that poor social support is a risk factor 
for CAD (Barth et al., 2010; Lett et. al, 2005; Uchino, 2007). One study examined the 
effects of social support on the self-care behaviors of patients and found that higher levels 
of social support were associated with increased self-care behaviors, including self-
weighing, medication and diet adherence (Sayers et. al, 2008). It was also found that 
spouses were more involved in patient care and support than other loved ones or friends. 
In regard to cardiac rehabilitation, a review of studies determining predictors of 
rehabilitation participation found that better social support was not only a positive 
predictor of attendance, but also of long term behavioral change (Jackson et al., 2004). It 
may be important to evaluate patients’ level of social support to know if they face any 
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barriers to treatment, as well as the extent to which they actively utilize the resources they 
have in others to help support positive behaviors.     
 
Knowledge 
Knowledge is referring to patient understanding of the risks, course, and treatment 
of cardiac disease. In a study assessing knowledge, researchers asked patients to complete 
questionnaires that evaluated their level of knowledge regarding risk factors and lifestyle 
changes (Alm-Roijer et al., 2004). Better knowledge about the disease was shown to 
improve patient adherence to lifestyle changes and medication regimens following a 
cardiac event (Alm-Roijer et al., 2004). A review of recent studies on patient compliance 
and adherence to medical treatment and lifestyle changes found that knowledge of 
condition was significantly correlated with adherence to self-care behaviors such as diet 
(van der Wal et al., 2005). Assessing patients’ knowledge of their treatment may be a 
good indicator of their ability to understand and adhere to treatment recommendations, 
and thus should be incorporated into studies of adherence.  
 
Medication Complexity 
For chronic conditions such as cardiac disease, medication regimens can become 
cumbersome as the number of medications and dosages increase. Research indicates that 
greater medication complexity is associated with poorer adherence among cardiac 
patients. Iskedjian et al. (2002) conducted a meta-analysis of studies examining dose-
frequency and adherence rates in hypertensive patients. It was found that medications that 
required multiple daily doses were associated with higher rates of non-adherence than 
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regimens requiring once or twice-daily doses. A study examining the validity of a 
medication adherence measure in over 1300 outpatients found that increased medication 
complexity was associated with a 45% reduction of being in the high-adherer group 
(Morisky et al., 2008). Therefore, it is important to include medication complexity in 
studies of adherence, as it may have critical implications for improving adherence among 
cardiac patients.  
 
Stress 
Stress comes in various forms such as work, marital, and financial, and research 
has indicated that chronic stress can result in adverse cardiac events (Rozanski et al., 
2005). Psychological stress in particular has been shown to have an adverse effect in 
patients with CAD (Krantz et al., 2000). Patients experiencing high levels of stress have 
an increased risk of a cardiac event, including myocardial infarctions and increased 
mortality (Krantz et al., 2000). While little literature is available on the effects of stress 
and adherence to treatment, there is evidence that increased stress reduces treatment 
adherence for cardiac patients. For example, patients who report high levels of stress are 
more likely to be non-adherent to their medication regimens (Morisky et al., 2008). Thus, 
it may be important to assess for stress level as a possible barrier to treatment adherence. 
 
Coping 
A chronic illness such as cardiac disease presents psychological challenges to 
patients and may test how they handle and manage their stress and condition. How 
patients cope with stress may help to predict how adherent they are to their treatment 
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regimens. One way in which patients cope with stress is through the use of optimism 
(Shepperd et al., 1996). A study that examined optimism and health behavior change in 
cardiac rehabilitation patients found higher levels of optimism were associated with 
greater success in behavior changes and meeting goals such as weight loss, lower body 
fat and lower saturated fat levels (Shepperd et al., 1996). Holahan et al. (1997) developed 
a model that highlighted coping skills, particularly approach-style coping, as an important 
variable in patients’ adjustment to their cardiac disease and their overall functioning over 
the next four years. Holahan et al.’s (1997) study showed that approach coping is 
negatively correlated with depressive symptoms. Furthermore, Holahan et al. (1997) 
found that depressive symptoms are associated with poorer outcomes and adherence, and 
increased mortality in cardiac patients. It has also been found that those who are in denial 
about their condition experience less hospitalization time initially, but are poorer adherers 
to exercise regimens and experience more hospitalizations during the following year than 
those who do not deny their condition (Taylor et al., 2007). Identifying patients with few 
or poor coping skills is important, as they may find adjusting to the lifestyle changes of 
managing heart disease difficult, therefore increasing their susceptibility to 
nonadherence.  
 
Depression 
A meta-analysis of studies evaluating adherence from 1968 to 1998 found that 
depressed patients are three times more likely to be non-compliant with treatment 
recommendations than non-depressed patients (DiMatteo, 2000). Depression is also 
associated with medication non-compliance in outpatients with coronary heart disease 
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(Gehi, 2005). Gehi (2005) assessed 940 patients with stable coronary heart disease for 
depression. Of those patients, 204 (22%) had major depression. Those diagnosed with 
major depression reported not taking medication as prescribed, forgetting medication, and 
deciding to skip doses compared to 5% of the 736 non-depressed patients (Gehi, 2005).  
In another study, 204 patients were given the Beck Depression Inventory three to five 
days following an acute myocardial infarction and interviewed again four months later 
(Ziegelstien, 2000). Patients with mild to moderate or major depression were less likely 
to adhere to lifestyle changes following myocardial infarction. Lane (2001) examined 263 
patients following a myocardial infarction for predictors of rehabilitation attendance, 
including depression and anxiety. It was found that higher levels of depression 
significantly predicted non-attendance in cardiac rehabilitation. Another hospital-based 
study did not find current depression to be a significant predictor of attendance; however, 
history of depression was a significant predictor of choosing to attend rehabilitation 
(Ades, 1992). These studies suggest more attention should be given to identifying and 
treating depression among cardiac patients as depression can have a negative effect on 
patient adherence.   
 
Anxiety 
It is theorized that anxiety, along with depression, may affect adherence by 
impairing focus, energy, motivation, and willingness to engage in treatment (DiMatteo, 
2000). Studies on anxiety and adherence to treatments for CAD in general suggest a link 
between the two, although the direction of the relationship remains unclear. For example, 
anxiety is associated with dietary non-compliance in patients with heart failure who are 
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being treated with an implantable cardioverter defibrillator (Luyster, 2009). Conversely, 
general anxiety about health may improve adherence due to a fear of negative outcomes 
(DiMatteo, 2000). While studies on the relationship between anxiety and adherence are 
limited, given that preliminary evidence suggests anxiety has an effect on treatment 
adherence, this relationship should be further studied.   
 
Relationships among Predictors 
While each of these aforementioned predictors has an independent effect on 
adherence, research indicates that they also have relationships with each other. For 
instance, gender has been shown to be correlated with knowledge of the disease; in 
particular, women display less knowledge (Kayaniyil et al., 2009). Female gender is also 
associated with persistent depression and anxiety symptoms in cardiac patients (Doering 
et al., 2010). Social support may also have a complex relationship with other predictors 
of treatment adherence in the cardiac population. Uchino’s (2006) model depicts social 
support having a bidirectional relationship with health behaviors and adherence, as well 
as psychological processes such as depression, anxiety, and appraisal. In this model, the 
psychological and behavioral aspects directly affect biological functioning, such as 
immune and cardiovascular processes (Uchino, 2006). Furthermore, stress has been 
found to be associated with negative coping style, low social support, younger age and 
female gender (Rozanski, 2005). One study found that type of stress and coping style had 
an effect on depressive symptoms (Rayburn et al., 2005). In that study, uncontrollable 
stressors of impoverished women predicted use of avoidant coping styles, which led to 
depressive symptoms (Rayburn et al., 2005). This type of effect of stress and coping on 
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psychosocial symptoms may also be present in the cardiac population. It is important to 
acknowledge the effect these variables may have on each other when understanding how 
they predict or effect overall treatment adherence.      
 
Anxiety and CAD 
Anxiety disorders and symptoms are prevalent in the cardiac population. In a 
large study examining the prevalence of depressive and anxiety disorders in over 129,000 
patients with cardiac disease age 45 and older, 16.6% had a lifetime diagnosis of anxiety 
disorders, compared to just 10% in those without cardiac disease, with the rate being 
almost twice as high for women (21.5%) as men (12.5%) (Fan et al., 2008). Coronary 
heart disease is also more prevalent among individuals who suffer from anxiety disorders. 
In a study assessing the prevalence of coronary heart disease in those with anxiety 
disorders, there was a three-fold increase of coronary heart disease in patients with a 
current anxiety diagnosis compared to those without an anxiety diagnosis (Vogelzangs et 
al., 2010). While the association between cardiac disease and anxiety has been 
demonstrated, studies of the mechanisms of the relationship have not provided consistent 
results.  
While the exact nature of the mechanisms underlying the relationship between 
cardiac disease and anxiety remains unclear, and while the literature is sparse, there is 
evidence to suggest a relationship between anxiety and clinical behaviors, such as 
maintaining a healthy diet, cigarette smoking, and physical inactivity in the cardiac 
population. For example, in past literature, anxiety has been linked to decreased physical 
activity and increased exercise intolerance due to uncomfortable symptoms (Taylor et al., 
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1987). However, it was found that although patients with panic symptoms have a 
generally higher heart rate, they were able to tolerate the same amount of exercise as 
controls (Taylor et al., 1987). These findings suggest that exercise intolerance reported by 
patients may be more psychological than physical in nature. A more recent study by 
Bonnet et al. (2005) found anxiety to be significantly correlated with physical inactivity 
in both men and women, and with unhealthy smoking and dietary behaviors in men. In 
addition, a global unhealthy behavior score was created combining poor diet, smoking, 
and physical inactivity and it was found that as anxiety increased, unhealthy behaviors 
significantly increased (Bonnet et al., 2005).  
Research has produced conflicting results regarding anxiety’s effect on cardiac 
patient outcomes. For instance, one study examining adverse clinical outcomes in over 
500 patients following hospital admission for a cardiac event assessed acute anxiety 
symptoms at baseline, one-year, and five-year follow-up (Kornerup, 2010). No 
association between anxiety and adverse outcomes was observed, including myocardial 
infarction, mortality, or stroke, when other factors such as physical activity, family 
history, medications, and smoking and alcohol behaviors, were accounted for. However, 
another longitudinal study that examined persistent, rather than incidental, comorbid 
anxiety and depressive symptoms in cardiac patients found that persistent symptoms 
significantly predicted mortality at 12-month follow-up (Doering et al., 2010). A meta-
analysis conducted on anxiety measurement in cardiac patients identified four studies that 
found anxiety to be a predictor of negative outcomes, while three studies found no 
association between anxiety and negative outcomes (Moser, 2007). Of note is the 
difference in anxiety measurements, such as assessing general versus specific anxiety, 
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which is common in the literature and may account for much of the variability found in 
current literature on anxiety’s relationship with heart disease.     
Anxiety is measured in various ways, depending on the aims of study. In general, 
it appears that anxiety is assessed using self-report measures such as the Brief Symptom 
Inventory (Doering et al., 2010), Hospital Anxiety and Depression Scale (Kornerup, 
2011), and General Anxiety Disorder 7 (Spitzer et al., 2006), which each measure general 
anxiety symptoms. Other studies have used criteria such as current or past anxiety 
disorder diagnosis (e.g., panic disorder or specific phobias) as an indicator of the 
presence of anxiety (Januzzi et al., 2000). Anxiety may be measured as acute or chronic, 
which may have different effects on experience and outcome. To the author’s knowledge, 
there are no known studies that examine the difference between the effects of acute or 
chronic anxiety on cardiac outcomes. It is possible that those who experience acute 
anxiety in response to their cardiac event that then reduces over time may have better 
outcomes than those who experience a more chronic, general anxiety. Consistent with 
this hypothesis, a study measuring chronic anxiety, or anxiety experienced persistently 
over time, found anxiety to increase the risk of death in patients with heart disease 
(Doering et al., 2010).    
 According to past research, cardiac symptoms and anxiety in cardiac patients have 
been mistaken for panic disorder (Jeejeebhoy et al., 2000). Panic-like anxiety has been 
shown to be an independent risk factor for cardiovascular death (Fleet, 1998). Therefore, 
it is important to understand how panic disorder is presenting in this population and how 
it can be treated early on, since untreated panic disorder can increase the risk of morbidity 
and mortality (Jeejeebhoy et al., 2000). Patients without CAD have presented with and 
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reported experiencing cardiac symptoms, but show no evidence of the disease. 
Jeejeebhoy et al. (2000) highlights that, of the 13 symptoms of a panic attack in the 
Diagnostic and Statistical Manual of Disorders, 4th Edition, only four are necessary for a 
diagnosis. (There are no significant changes to these criteria in the DSM-V.) There are 
four cardiovascular symptoms listed, which means that an individual could be diagnosed 
with panic disorder purely based on cardiac symptoms. However, the fear of and/or 
attention to cardiac symptoms may not actually be related to panic disorder; it may be 
better accounted for by what is known as heart-focused (or cardiac) anxiety.   
Heart-focused anxiety is a relatively new term used to describe the fear of 
cardiac-related stimuli and sensations because of their perceived negative consequences 
(Eifert, Zvolensky et al., 1999b). It comprises three factors: fears about heart sensations, 
heart-focused attention and monitoring, and avoidance of behaviors thought to cause a 
heart event, such as a heart attack. Heart-focused anxiety is different from general anxiety 
because it is specific to the heart. Many studies, including those previously mentioned, 
have used general anxiety measures to assess for anxiety in cardiac patients. These 
measures may assess anxiety, but do not help to determine the source of that anxiety, 
perhaps because they are too general in scope. Heart-focused anxiety is specific to heart 
related events, sensations, and functioning (Eifert, Zvolensky et al., 1999b). This type of 
anxiety is most common in patients who have experienced a cardiac event and are more 
concerned for their health, individuals with a family or personal history of CAD, and 
those with little risk who are still overly concerned about the well-being of their heart 
(Eifert, Zvolensky et al., 1999b). In an analysis by Zvolensky et al. (2008), the authors 
point out that there are patients with non-cardiac chest pain that may have a specific fear 
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and sensitivity related to their heart and possible negative consequences, but do not have 
this same fear for other bodily sensations. They do not experience the cognitive 
symptoms of panic, such as fear of dying, and therefore do not meet the panic disorder 
criteria. The authors use the term cardiophobia to address this fear, detailing that heart-
focused anxiety is a persistent catastrophizing of symptoms relating to the heart.    
Heart-focused anxiety is considered a symptom of anxiety rather than an anxiety 
disorder, and therefore is not included the International Classification of Diseases nor the 
Diagnostic and Statistical Manual of Mental Disorders. As a result, patients displaying 
heart-focused anxiety are often given a diagnosis of panic disorder because the symptoms 
are similar (Fisher, 2011). Patients with panic disorder and coronary artery disease who 
report symptoms related to panic disorder report more distress (Fleet, 1996). This distress 
leads them to utilize medical services for symptoms they perceive to be related to their 
medical condition, when in fact they are not (Fleet, 1996). As they are listed in the DSM-
IV, some of the possible cardiovascular symptoms (i.e., pounding or accelerated heart 
rate, chest paint or discomfort) and psychological symptoms (i.e., fear of losing control or 
going crazy, fear of dying) could possibly be a byproduct of chronic heart-focused 
anxiety, and specifically increased attention to heart sensations and fear.  It is possible 
that these patients are experiencing panic related anxiety symptoms that are specific to 
their heart and would be better served by an earlier diagnosis of heart-focused anxiety.  
It is important that heart-focused anxiety, as commonly measured by the Cardiac 
Anxiety Questionnaire (Eifert, 1999a), is differentiated from panic disorder. Research has 
shown that cardioprotective beliefs, cardiac distress, and panic explain 62% of the 
variance in avoiding physical activity and work, and 57% of the variance in emergency 
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department utilization (Aikens, 1999). Aikens’ (1999) study shows that those with fear 
related to their heart are avoiding daily activities and using more unnecessary medical 
resources to ease their anxiety. As such, it is possible that heart-focused anxiety may 
cause patients to avoid positive health behaviors, such as exercise, because of fear of a 
cardiac event. The Cardiac Anxiety Questionnaire may be a useful tool for tailoring 
clinical assessment in high-volume settings (Zvolensky, 2008). If individuals high in 
cardiac anxiety can be identified and treated, it could lead to an increase of healthy 
behaviors and a reduction of unnecessary medical resource utilization. In fact, more 
recent research suggests that an earlier diagnosis of heart-focused anxiety may beneficial 
to cardiac patients through a decrease in functional impairment and an increase in quality 
of life (Zvolensky, 2008).  
 Heart-focused anxiety has similarities with depression and anxiety, which are 
highly correlated with CAD (Gehi, 2005; McCann et al., 2005). Similar to general 
anxiety, predictors of heart-focused anxiety include social support and age (Fischer, 
2011). A previous study examined heart-focused anxiety in a community sample of 2,396 
individuals and found that there was a positive linear relationship between Cardiac 
Anxiety Questionnaire scores and age, as well as relationship status (Fischer, 2011). The 
study also found that those in a relationship generally displayed less heart-focused 
anxiety. The association between heart-focused anxiety and relationship status is thought 
to be accounted for by an increase in emotional support for those with close relationships. 
Also, those with a higher education report lower cardiac anxiety scores, possibly due to 
stronger cognitive skills and/or more knowledge to make better healthcare decisions 
(Fischer, 2011).  
20 
When compared to those without a diagnosis of CAD, those with a cardiac 
diagnosis experience significantly higher mean scores for heart-focused attention and 
fear/worry factors (Marker, 2008). Since anxiety and heart-focused anxiety are predicted 
by similar factors, they may also have similar effects on the course of CAD. A study 
examining heart-focused anxiety in relation to anxiety and depression found the 
avoidance and fear factors to be independently related to general anxiety and depression 
(Hamang, 2011), and patients with higher levels of general anxiety were at higher risk for 
CAD. Since patients with CAD and depression and anxiety have poorer treatment 
adherence (Bonnet et al., 2005; Gehi, 2005; Lane, 2001), it is possible that those with 
heart-focused anxiety will have similar, or perhaps even worse, outcomes given the 
specificity of heart-focused anxiety.             
 
Preliminary Research 
 The author conducted a preliminary study that examined whether heart-focused 
anxiety and its subscales were significant predictors of cardiac rehabilitation attendance 
(a proxy for adherence), above and beyond known predictors, especially general anxiety. 
While the results were not significant, the interpretation of effect sizes revealed that 
patients with higher general anxiety and higher levels of fear and avoidance may be more 
likely to attend cardiac rehabilitation, while those with higher levels of general heart-
focused anxiety and attention may be less likely to attend cardiac rehabilitation. Most 
notably, the subscales of heart-focused anxiety each had larger effects on attendance than 
general anxiety did, indicating a possible stronger relationship between recommended 
treatment adherence and heart-focused anxiety than with general anxiety. That study had 
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several limitations, including small sample size, limited assessment of predictors of 
adherence, and highly restricted measurement of adherence. Those limitations will be 
addressed in the current study to better understand the relationship among the 
aforementioned variables, specifically the role of different forms of anxiety, with 
adherence in the cardiac population. Unlike in the previous study, the current study will 
examine factors that lead to adherence to cardiac treatments in general, not just adherence 
to cardiac rehabilitation attendance. A greater number of theoretically known predictors 
of treatment adherence will be included in the present study to control for their effect on 
treatment adherence. In addition, the current study will involve a larger sample size to 
increase statistical power.  
 
The Current Study 
 Coronary artery disease is the leading cause of death in North America. Anxiety is 
a potential barrier to treatment for CAD; especially in light of the fact that anxiety 
disorders are the most prevalent class of psychological disorders in the world and anxiety 
is a significant independent predictor of CAD (McCann et al., 2005; Roest, 2010; World 
Health Organization, 2004). However, there are few studies on the relationship between 
anxiety and adherence to cardiac treatment, and those that exist have produced equivocal 
results. One reason for these mixed results may be that previous studies have measured 
general anxiety rather than heart-focused anxiety, which is a type of anxiety that is 
specific to heart related events, sensations, and functioning.   
The overarching aim of the current study is to test predictors of treatment 
adherence, including heart-focused anxiety, in a sample of patients who have a history of 
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CAD. More specifically, the goals of the current study are to (1) identify whether heart-
focused anxiety is a significant predictor of adherence, as measured by blood pressure 
levels and adherence to medication, dietary restrictions, and exercise recommendations; 
(2) determine if heart-focused anxiety is a better predictor of adherence than general 
anxiety; and (3) determine if heart-focused anxiety is a better predictor of treatment 
adherence above and beyond previously reported identified predictors of adherence (i.e., 
gender, age, knowledge, stress, social support, depression, and coping style). We 
hypothesize that higher levels of heart-focused anxiety will be a significant predictor of 
treatment adherence. Specifically, it is hypothesized that higher levels of heart-focused 
anxiety will negatively impact adherence to exercise recommendations due to fear of 
inducing a heart-related event. However, it is hypothesized that higher levels of heart-
focused anxiety may actually improve adherence to diet and medication regimens due to 
the desire to avoid negative health consequences. We also hypothesize that heart-focused 
anxiety will be a better predictor of adherence to treatment than general anxiety. Lastly, 
we hypothesize that heart-focused anxiety will be a better predictor than other known 
predictors of treatment adherence.  
If it is found that heart-focused anxiety is a significant predictor of treatment 
adherence, then it may be warranted to utilize measures of heart-focused anxiety in 
clinical settings instead of measures of general anxiety. Moreover, assessing for heart-
focused anxiety may better capture the experience of anxiety for the cardiac population, 
given that the current literature is variable in describing how anxiety presents for cardiac 
patients. Specific interventions could target individuals who report higher levels of 
cardiac anxiety to help reduce that anxiety, which could lead to improved adherence. 
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CHAPTER TWO 
METHOD 
 
Participants 
 This study included participants ages 29-96 (M = 69.24, SD = 14.18; 
56.9% female) who were recruited from the Loma Linda University Medical center, had 
a diagnosis of cardiac disease, and received or were offered treatment during 2013 for 
their heart condition. Participant demographic data are presented in Table 1. Participants 
were excluded if they had a cognitive disorder, such as any neurocognitive disorder, 
determined by medical chart review, or if they were unable to read and write in English. 
Eight hundred eighty-nine possible participants were contacted, 222 people agreed to 
participate, and 65 actually participated. 
 
Table 1. Demographic Characteristics of Sample 
 Patients (n = 65)  
 M SD  
Age (years) 68.84 14.18  
    
 N %  
Gender    
     Male 28 43.1  
     Female 37 56.9  
Ethnicity    
      Caucasian 51 78.5  
      Hispanic 8 12.3  
      African-American 5 7.7  
      Other 1 1.5  
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Materials 
Demographics 
Potential demographic predictors included gender, age, ethnicity, education, and 
current height and weight. Education was determined by number of years of education. 
All demographic data were self-reported.  
 
Anxiety 
 Anxiety was measured using the Generalized Anxiety Disorder 7 (GAD-7) 
questionnaire (see Appendix A), which has also been designed for medical populations 
(Spitzer et al., 2006). Participants responded to the question: “Over the last 2 weeks, how 
often have you been bothered by any of the following problems?” on a scale of 0 (“Not at 
All”) to 3 (“Nearly every day”) regarding items such as “Worrying too much about 
different things” or “Becoming easily annoyed or irritable.” A score of 1-5 indicates mild 
anxiety, 6-10 indicates moderate anxiety, and 11-15 indicates severe anxiety. The GAD-7 
is reliable (α = .92), with adequate specificity (82%) and sensitivity (89%; Spitzer et al., 
2006). Reliability for the present study is α = .92.  
The State-Trait Anxiety Inventory – Trait version (STAI-Trait; Speilberg, 1970) 
was used to measure trait anxiety, which is defined as a general propensity to experience 
anxiety. It includes 20 items that participants respond to on a Likert scale ranging from 1 
(“Almost Never”) to 4 (“Almost Always”). Some items include “I am a steady person,” 
“I feel nervous and restless,” and “I worry too much over something that doesn’t really 
matter” (see Appendix B). Higher scores indicate higher levels of trait anxiety. The Trait 
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Anxiety scale is widely used and has a high reliability of α = .92 (Ramanaiah, 1983). 
Reliability for the present study is α = .93.  
 
Panic Disorder 
Panic disorder was assessed using the Panic Disorder Severity Scale-Self Report 
(PDSS-SR; Houck et al., 2002; see Appendix C). This seven-item measure has been 
adapted from the Panic Disorder Severity Scale, which was a clinical interview to assess 
for panic disorder severity and has been used in clinical and research settings. Items ask 
respondents about the frequency, duration, intensity of panic attacks, as well as other 
features relevant to the disorder. Clinical scores in non-agoraphobic patients included: 0-
1 = “normal,” 2-5 = "borderline," 6-9 = "slightly ill," 10-13 = "moderately ill," and 14 
and above = "markedly ill" (Furukawa et al., 2009). The PDSS-SR has demonstrated high 
reliability (α = .917) as compared to the original clinical interview, which also 
demonstrated high reliability (α = .923) (Houck et al., 2002). Reliability for the present 
study is α = .93.  
 
Heart-focused Anxiety 
Heart-focused Anxiety was measured using the Cardiac Anxiety Questionnaire 
(CAQ). The CAQ (see Appendix D) is an 18-item questionnaire comprising three 
subscales (fear, avoidance, and attention) that are used to evaluate the more specific 
symptom of heart-focused anxiety in clinical populations (Eifert et al., 1999a). 
Participants responded to each item on a Likert scale of 0 (“Never”) to 4 (“Always”) 
regarding items such as “I avoid exercise or other physical work.” Higher scores indicate 
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higher levels of HFA. The entire CAQ has good internal consistency reliability (α = 
0.83), as does each of the three subscales (fear, α = 0.83; avoidance, α = 0.82; and 
attention, α = 0.69) (Eifert et al., 1999a). The CAQ was found to have a high correlation 
with the Anxiety Sensitivity Index, thus demonstrating good convergent validity (r = 
0.69; Eifert et al., 1999a). Reliability for the present study is α = .89.     
 
Depression 
Depression was measured using the Center for Epidemiologic Studies-Depression 
(CES-D) scale (Radolff, 1977; see Appendix E). This scale is a 20-item self-report 
measure designed to assess depression severity in the general population and has also 
been used in clinical populations. Participants responded to items such as “I was bothered 
by things that don’t usually bother me” and “I felt fearful,” regarding the past week. 
Responses range from “Rarely or none of the time (less than 1 day)” to “Most or all of 
the time (5-7 days).” A cut-off score of 16 indicates significant symptomatology. 
Previous research has demonstrated high internal consistency (α = 0.87; Pennix et al., 
2001), as well as high specificity (88%) and sensitivity (100%; Beekman et al., 1997). 
Reliability for the present study is α = .94.  
 
Knowledge 
Knowledge was measured using the Coronary Artery Disease Education 
Questionnaire (CADE-Q; de Milo Ghisi et al., 2013; see Appendix F). This 19-item 
measure assesses patient knowledge in four domains: pathophysiology, risk factors, 
diagnosis and treatment, and exercise.  Items ask questions about CAD and 
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recommendations and offer four responses, each demonstrating a different level of 
knowledge. For example, one item asks “Which of the following dietary components best 
describes a nutritional plan for persons with CAD?” Possible responses to this item 
include: “(a) A diet with reduced salt, low fat and rich in fiber,” “(b) A diet based on 
whole grains, vegetables, fish, extra virgin olive oil and nuts,” “(c) An unrestricted diet, 
because diet is not a relevant factor,” and “(d) I don’t know”. Higher scores indicate 
higher levels of knowledge. The measure has a good internal consistency (α = 0.81; de 
Milo Ghisi et al., 2013). Reliability for the present study is α = .78.  
 
Stress 
Psychosocial stress was measured using the Perceived Stress Scale (PSS; see 
Appendix G), which measures patients’ perceived levels of stress (Cohen et al., 1983).  
This ten-item scale measures how stressful one perceives his or her life to be, and is 
highly correlated with stressful life events, depression, physical symptoms, anxiety, and 
use of primary care services (Cohen et al., 1983).  Participants responded to items such as 
“In the past month, how often have you found that you could not cope with all the things 
you had to do?” Responses range from 0 (“Never”) to 4 (“Very often”). A score of 0-13 
indicates low stress, 14-26 indicates moderate stress, and 27-40 indicates high perceived 
stress. This measure has demonstrated acceptable internal consistency (α = 0.78; Cohen 
& Williamson, 1988). Reliability for the present study is α = .78. 
 
Social Support 
Perceived support was measured using the Multidimensional Scale of Perceived 
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Social Support (Zimet et al., 1998; Appendix H). The subscales assess levels of support 
from friends, family, and significant others. Participants responded to 12 items such as “I 
can talk about my problems with my friends” and “I have a special person who is a real 
source of comfort to me.” Responses range on a seven-point scale from “Very strongly 
disagree” (1) to “Very strongly agree” (7). Higher scores indicate higher levels of 
perceived social support. The scale reliability ranges from α = 0.84 to α = 0.92 for 
differing participant groups, such as high school students, pregnant women receiving 
care, and medical residents (Zimet et al., 1990). Reliability for the present study is α = 
.93. 
 
Coping 
Coping was measured using the Brief COPE (Carver, 1997; see Appendix I). This 
28-item measure includes 14 scales assessing coping styles, including Active Coping, 
Planning, Positive Reframing, Acceptance, Humor, Religion, Using Emotional Support, 
Using Instrumental Support, Self-Distraction, Denial, Venting, Substance Use, 
Behavioral Disengagement, and Self-Blame (Carver, 1997). Items such as “I have been 
taking action to make the situation better” are responded to on a scale of 0 (“I haven’t 
been doing this at all”) to 3 (“I’ve been doing this a lot”). Examined separately, each 
scale has demonstrated adequate internal reliability of αs = 0.64 to 0.90, except Venting 
(α = 0.50), Denial (α = 0.54), and Acceptance (α = 0.57).  
To reduce the number of variables used in this study, the 14 subscales were 
combined into two separate overarching subscales: Negative Coping and Positive 
Coping. Carver (1997) noted that the subscales can be used in various ways, and 
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identified that the BRIEF COPE represents general adaptive and problematic coping 
styles. Thus, we combined the subscales to represent both Positive Coping, which 
included Active Coping, Planning, Positive Reframing, Acceptance, Humor, Religion, 
Using Emotional Support, Using Instrumental Support; and Negative Coping, which 
included Self-Distraction, Denial, Venting, Substance Use, Behavioral Disengagement, 
and Self-Blame. Higher scores indicate more usage of a particular coping style. 
Reliability for the present study for Positive Coping is α = .84 and for Negative Coping is 
α = .64.  
 
Medication Complexity 
Medication complexity measurement was modeled after a two-item index that 
asks participants how many medications they take daily for their cardiac condition, and 
how many times a day they should be taken (Morisky, 2008). In this study, participants 
were asked to list all of their current medications, what they believe each one is for, and 
how often each day they are prescribed to take each one. Complexity was measured by 
taking a total sum of the number of medications taken daily. Since each medication has 
different dosage schedules, the sum of total daily medications represents the minimum 
complexity of medication burden (see Appendix J).  
 
Adherence 
Medication adherence was measured using the Medication Adherence Measure 
(Morisky, 2008; Appendix K). This eight-item self-report scale measures a participant’s 
adherence to his or her hypertension medication. Participants respond “yes or no” to 
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items such as “Do you sometimes forget to take your high blood pressure medication?” or 
“When you travel or leave home, do you sometimes forget to bring along your 
medications?” This scale has been shown to be reliable (α = 0.83) and valid in a clinical 
cardiac outpatient population (Morisky, 2008). Sensitivity (93%) was adequate; however, 
specificity (53%) was not. Reliability for the present study is α = .67. 
 Most recent blood pressure readings, LDL, and HDL were obtained from either 
patient medical records or self-reported from the patient only if the information was not 
available in medical records. Their values were identified as non-adherent if found to be 
outside of the healthy normal limits (0 = within normal range, 1 = high or uncontrolled). 
Blood pressure is considered not controlled if systolic pressure is at or above 140 mm Hg 
and/or diastolic pressure is at or above 90 mm Hg. LDL is considered normal if less than 
100 mg/dL and high if above 100 mg/dL. HDL is considered normal if over 60 mg/dL 
and unhealthy if under 60 mg/dL (0 = normal, 1 = low or unhealthy). 
 Adherence to dietary and exercise recommendations was assessed using an ten-
item scale created by the author for this study using the American Heart Association’s 
recommended lifestyle changes for those with cardiovascular disease (Lichtenstein et al., 
2006). These items ask about the frequency and type of exercise engaged in each week, 
as well as adherence to dietary suggestions (see Appendix L). To represent adherence to 
diet and exercise recommendations, items were coded as followed (1) or not followed (0) 
and summed so a higher score represents a higher level of adherence.   
 
Procedure 
 Patients who had previously received treatment for a cardiac diagnosis at the 
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Loma Linda University Medical Center were recruited to participate. The cardiac 
rehabilitation staff provided contact information for the patients. Patients were contacted 
via phone and asked to participate in the study by completing a psychosocial 
questionnaire by mail or online. The mailed questionnaire included an explanatory letter 
and consent forms, for both participation and consent for research personnel to access 
medical records, to be signed and returned with the completed questionnaire. Participants 
were provided a self-addressed stamped envelope to return the questionnaire, and the 
opportunity to be included in a raffle drawing for one of three $50 Amazon gift cards as 
incentive for participating in the study. To increase questionnaire return rate, up to three 
follow-up phone calls were conducted as a reminder starting two weeks after the 
questionnaire was mailed. Additional survey packages were mailed upon request.  
 Any participants who opted to complete the questionnaire online were sent an 
email with a confidential link to the survey, available through Qualtrics. The consent 
forms were presented first; participants continued to the questionnaire only if they 
provide informed consent. Participants were contacted by phone and/or email two weeks 
after the initial email was sent if they had not completed the questionnaire. Those who 
completed the survey online or by mail were automatically be entered in a drawing for 
the gift card upon completion of the questionnaire. The drawing will take place after 
collection of the questionnaires is complete (data collection is ongoing to obtain a larger 
sample size). 
 The questionnaire included a demographic survey and all of the measures listed 
above. Following the receipt of completed surveys, patient medical records were 
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reviewed for recent blood pressure, LDL, and HDL readings. Patients were contacted via 
phone to obtain any missing questionnaire data, such as blank or skipped items.  
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CHAPTER THREE 
RESULTS  
 
 Hypotheses were tested in five separate regression models predicting five 
different measures of treatment adherence: lifestyle adherence, medication adherence, 
LDL, HDL, and blood pressure. Hierarchical multiple linear regression models were used 
to test hypotheses for lifestyle and medication adherence. Hierarchical binomial logistic 
regression models were used to test hypotheses for LDL, HDL, and blood pressure 
adherence.  
Due to the large number of potential covariates and independent variables in this 
study, bivariate correlations among all variables and outcome measures, using a cutoff 
score of r = .3, in combination with theory, research, logic and power analyses were used 
to determine which predictors to include. All variables that were significantly correlated, 
or non-significantly correlated at r ≥ .3, with each outcome measure were included in the 
respective models. General anxiety and CAQ Fear, Avoidance, and Attention subscales 
were included in all models regardless of correlation because they were the primary 
variables of interest for this study. Assumptions of both multiple linear regression and 
hierarchical binomial logistic regression were tested prior to analysis and are explained 
below for each model separately. Descriptive statistics and correlations among the 
variables of interest are presented in Tables 2 and 3, respectively.  
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Table 2. Means and Standard Deviations of Predictor Variables 
 
 M SD 
General Anxiety (GAD7) 3.83 4.45 
STAI-Trait 36.94 11.46 
Panic 0.34 0.59 
Total Cardiac Anxiety (CAQ) 1.48 0.74 
Fear  1.45 0.75 
Avoidance 1.76 1.11 
Attention 1.23 0.88 
Depression (PHQ9) 12.12 12.61 
Knowledge 35.26 10.14 
Stress 10.85 6.09 
Social Support 65.74 15.83 
Positive Coping 38.66 11.74 
Negative Coping 18.73 5.34 
Total Meds 9.21 5.15 
 
 
  
3
5
 
 
 
Table 3. Correlations among Predictor Variables  
 GAD7 
STAI-
Trait 
Panic CAQ Fear Avoidance Attention PHQ9 Knowledge 
GAD7 1         
STAI-Trait .763** 1        
Panic .481** .57** 1       
CAQ .541** .41** .522** 1      
Fear  .511** .43** .527** .887** 1     
Avoidance .328** .178 .236 .77** .47** 1    
Attention .52** .42** .558** .826** .711** .412** 1   
PHQ9 .715** .823** .722** .526** .554** .299* .559** 1  
Knowledge -.046 -.096 .084 .109 .127 .116 .004 .003 1 
Stress .705** .771** .645** .448** .505** .196 .413** .793** .03 
Social 
Support 
-.309** -.541** -.426** -.155 -.152 -.063 -.176 -.512** .008 
Positive 
Coping 
.72 -.115 .208 .233 .202 .124 .274* .041 .199 
Negative 
Coping 
.496** .516** .53** .428** .412** .238 .431** .534** .052 
Total Meds .106 -.057 .008 .316* .118 .415** .256* -.02 -.006 
       *p < .05. **p < .001.  
  
3
6
 
 
 
Table 3. Correlations among Predictor Variables (continued) 
 
 
Stress 
Social 
Support 
Positive 
Coping 
Negative 
Coping 
Total 
Meds 
GAD7 
 
     
STAI-Trait 
 
     
Panic 
 
     
CAQ 
 
     
Fear  
 
     
Avoidance 
 
     
Attention 
 
     
PHQ9 
 
     
Knowledge 
 
     
Stress 
 
1     
Social Support 
 
-.446** 1    
Positive Coping 
 
.07 .133 1   
Negative 
Coping 
 
.573** -.173 .329** 1  
Total Meds 
 
-.084 .027 .224 .014 1 
       *p < .05. **p < .001.  
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Model 1: Lifestyle Adherence 
A hierarchical multiple linear regression analysis was conducted to test 
medication complexity, knowledge, positive coping, general anxiety, fear, avoidance, and 
attention as predictors of lifestyle adherence, which was measured by the ten-item scale 
created for this study (See Appendix L). Total medications, knowledge (CADE-Q), and 
positive coping (BRIEF COPE subscale score) were added in the first step of the 
analysis; general anxiety (GAD-7 score) in the second; and CAQ fear, avoidance, and 
attention in the final step, as the variables of primary interest. Fifty-nine participants 
provided data on the variables used in this analysis. Prior to analysis, we tested for 
outliers, multicollinearity, and the assumptions of linear regression. There were no 
problems with outliers or multicollinearity, and only the assumption of homoscedasticity 
was violated. We corrected for this violation by applying a square-root transformation to 
our outcome variable, lifestyle adherence, and re-running the regression model predicting 
this transformed variable. Using the methods outlined in Cohen, Cohen, Aiken, and West 
(2003), we determined that we had 99% power to detect a significant effect of R2 = .327 
at α = .05 and with seven predictors. Power analyses for individual predictors indicated 
that we had 99% power to detect both moderate and large effect sizes of .25 and .64, 
respectively, and greater than 40% power to detect a small effect size of at least .04 
(Cohen et al., 2003; Ferguson, 2009). The results of the final regression model are shown 
in Table 4. 
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Table 4. Results of Hierarchal Linear Regression Analyses Predicting Lifestyle 
Recommendation Adherence  
      95% CI 
Predictor b SE t p sr2 Lower Upper 
Total 
Medications 
.015 .011 1.44 .156 .027 -.006 .037 
Knowledge .011 .005 2.241 .029 .066 .001 .022 
Positive 
Coping 
.011 .004 2.628 .011 .091 .003 .02 
General 
Anxiety 
-.001 .013 -.085 .932 .0001 -.027 .025 
Fear -.053 .1 -.534 .595 .004 -.254 .147 
Avoidance .004 .05 .076 .94 .00008 -.097 .105 
Attention .087 .086 1.011 .317 .013 -.086 .261 
 
 
The overall model fit was R2adj = .235, F(7,51) = 3.54, p < .05, indicating that the 
optimal linear combination of all predictors accounted for 23.5% of the variance in 
lifestyle adherence. Knowledge score significantly and independently predicted lifestyle 
adherence, such that as knowledge score increased by one point, lifestyle adherence 
increased by .011 units, 95% CI[.001, .022], p < .05, sr2 = .066. Positive coping also 
significantly predicted lifestyle adherence, such that as positive coping increased by one 
point, lifestyle adherence increased by .011 units, 95% CI[.003, .02], p < .05, sr2 = .091. 
Total medications (95% CI[-.006, .037], p > .1, sr2 = .027), general anxiety (95% CI[-
.027, .025], p > .9, sr2 = .0001, CAQ fear (95% CI[-.254, .147], p > .5, sr2 = .004), CAQ 
avoidance (95% CI[-.097, .105], p > .9, sr2 = .00008) and CAQ attention (95% CI[-.086, 
.261], p > .3, sr2 = .013) did not significantly predict lifestyle adherence.  
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Model 2: Medication Adherence 
A hierarchical multiple linear regression analysis was conducted to test panic, 
depression, negative coping, general anxiety, fear, avoidance, and attention as predictors 
of medication adherence, as measured by the Medication Adherence Measure (Morisky, 
2008). Panic (PDSS-R score), depression (CESD score), and negative coping (BRIEF 
COPE subscale score) were added in the first step of the analysis; general anxiety (GAD-
7 score) in the second; and CAQ fear, avoidance, and attention in the final step, as the 
variables of primary interest. Sixty participants provided data on the variables used in this 
analysis. Prior to analysis, we tested for outliers, multicollinearity, and the assumptions of 
linear regression. There were no problems multicollinearity. However, there were four 
potential outliers and the assumptions of normality and homoscedasticity were violated. 
The outliers were kept in the analyses due to small sample size. Attempts to transform the 
model using square root, log, and inverse transformations of the medication adherence 
variable were unsuccessful in correcting violations of assumptions, so the original model 
with the untransformed outcome variable was used. Using the methods outlined in 
Cohen, Cohen, Aiken, and West (2003), we determined that we had 87% power to detect 
a significant effect of R2 = .136 at α = .05 and with seven predictors. Power analyses for 
individual predictors indicated that we had > 95% and 99% power to detect moderate and 
large effect sizes of .25 and .64, respectively, and approximately 40% power to detect a 
small effect size of at least .04 (Cohen et al., 2003; Ferguson, 2009). The results of the 
final regression model are shown in Table 5.  
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Table 5. Results of Hierarchal Linear Regression Analyses Predicting Medication 
Adherence  
 
      95% CI 
Predictor b SE t p sr2 Lower Upper 
Panic -.077 .462 -.167 .868 .0004 -1.003 .849 
Depression -.024 .026 -.923 .36 .014 -.075 .028 
Negative 
Coping -.061 .043 -1.404 .166 .033 -.148 .026 
General 
Anxiety .079 .06 1.314 .195 .029 -.042 .2 
Fear -.207 .389 -.532 .597 .005 -.987 .574 
Avoidance .041 .196 .207 .837 .0007 -.352 .433 
Attention -.031 .341 -.09 .929 .0001 -.716 .654 
 
 
The overall model fit was R2adj = .02, F(7,52) = 1.168, p > .05, indicating that the 
optimal linear combination of all the predictors only accounted for 2% of the variance in 
medication adherence. Panic (95% CI[-1.003, .849], p > .8, sr2 = .0004), depression (95% 
CI[.075, .028], p > .3, sr2 = .014), negative coping (95% CI[-.148, .026], p > .1, sr2 = 
.033), general anxiety (95% CI[-.042, .2], p > .1, sr2 = .029), CAQ fear (95% CI[-.987, 
.574], p > .5, sr2 = .005), CAQ avoidance (95% CI[-.352, .433], p > .8, sr2 = .0007) and 
CAQ attention (95% CI[-.716, .654], p > .9, sr2 = .0001) did not significantly predict 
lifestyle adherence.  
 
Model 3: LDL Adherence 
A hierarchical binomial logistic regression analysis was conducted to test gender, 
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positive coping, general anxiety, CAQ fear, CAQ avoidance, and CAQ attention as 
predictors of LDL adherence (0 = normal, 1 = high). Forty participants provided data on 
the variables used in this analysis. Gender and positive coping were added in the first step 
of the analysis; general anxiety (GAD-7 score) in the second; and CAQ fear, avoidance, 
and attention in the final step, as the variables of primary interest. Prior to analysis, we 
tested for outliers, multicollinearity, and the assumptions of logistic regression. No 
violations of multicollinearity or the assumptions of logistic regression were detected. 
Two potential outliers were identified, but we decided to keep the participants in the data 
analysis due to the small sample size. Using G*Power 3.1 (Faul et al., 2009), power was 
excellent at 0.96. The results of the analysis are shown in Table 6. 
 
Table 6. Results of Hierarchal Logistic Regression Analyses Predicting LDL 
Cholesterol Non-Adherence  
 
     95% CI 
Predictor b SE OR p Lower Upper 
Gender 1.799 .83 1.188 .03 1.188 30.725 
Positive Coping .101 .044 1.106 .022 1.014 1.206 
General Anxiety .123 .115 1.13 .287 .902 1.417 
Fear 1.305 1.114 3.686 .242 .415 32.734 
Avoidance .06 .429 1.061 .89 .458 2.458 
Attention -1.601 .962 .202 .096 .031 1.328 
Note. The reference group for this model is patients with low (healthy) LDL. 
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A test of the full model against a constant only model was statistically significant, 
indicating that the predictors as a set reliably distinguished between those with normal 
and high LDL, χ2(6) = 14.43, p < .05. In the final model, odds ratios indicated that there 
was a 504% increase in the odds of having high or unhealthy LDL if the participant was 
male (OR = 6.042, 95% CI[1.188, 30.725],  p < .05), and an 10.6% increase in the odds 
of having high LDL with every one-point increase in positive coping (OR = 1.106, 95% 
CI[1.014, 1.206], p < .05). The following relationships were not statistically significant, 
but the effect sizes (ORs) were large enough to warrant interpretation. There was a 13% 
increase in the odds of having high LDL with every one-point increase in general anxiety 
(OR = 1.13, 95% CI[.902, 1.417], p > .2). The odds of having high LDL increased by 
26% with every one-point increase on the Fear subscale of the CAQ (OR = 3.686, 95% 
CI[.415, 32.734], p > .2). The odds of having high LDL increased by 6% with every one-
point increase on the Avoidance subscale of the CAQ (OR = .1.061, 95% CI[.458, 2.458], 
p > .8). Lastly, the odds of having high LDL decreased by 79% with every one-point 
increase on the Attention subscale of the CAQ (OR = .202, 95% CI[.031, 1.328], p > .09).  
 
Model 4: HDL Adherence 
A hierarchical binomial logistic regression analysis was conducted to test negative 
coping, general anxiety, CAQ fear, CAQ avoidance, and CAQ attention as predictors of 
HDL adherence (0 = normal, 1 = low). Thirty-eight participants provided data on the 
variables used in this analysis. Negative coping was added in the first step of the analysis; 
general anxiety (GAD-7 score) in the second; and CAQ fear, avoidance, and attention in 
the final step, as the variables of primary interest. Prior to analysis, we tested for outliers, 
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multicollinearity, and the assumptions of logistic regression. No violations of 
multicollinearity or the assumptions of logistic regression were detected. One extreme 
outlier was identified and removed from the analysis. Using G*Power 3.1 (Faul et al., 
2009), power was excellent at 0.99. Results of the analysis are shown in Table 7.  
 
Table 7. Results of Hierarchal Logistic Regression Analyses Predicting HDL 
Cholesterol Non-Adherence  
 
     95% CI 
Predictor b SE OR p Lower Upper 
Negative Coping -.059 .099 .943 .55 .777 1.144 
General Anxiety -.065 .148 .937 .659 .701 .1252 
Fear .852 1.223 2.344 .486 .213 25.733 
Avoidance .631 .528 1.879 .232 .668 5.289 
Attention .009 1.025 1.009 .993 .135 7.527 
Note. The reference group for this model is patients with high (healthy) HDL. 
 
 
A test of the full model against a constant only model was not statistically 
significant, indicating that the predictors as a set did not reliably distinguish between 
those with normal and low HDL, χ2(5) = 4.38, p > .05. The Attention subscale of the 
CAQ was not a statistically or clinically significant predictor of HDL (OR = 1.009, 95% 
CI[.135, 7.527], p > .9). None of the other predictors was statistically significant, but 
their effect sizes (ORs) were large enough to warrant interpretation. In the final model, 
odds ratios suggested that there was a 5.7% decrease in the odds of having low HDL with 
every one-point increase in negative coping (OR = .943, 95% CI[.777, 1.144], p > .5). 
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There was a 6.3% decrease in the odds of having low HDL with every one-point increase 
in general anxiety (OR = .937, 95% CI[.701, 1.252], p > .6). The odds of having low 
HDL increased by 134% with every one-point increase on the Fear subscale of the CAQ 
(OR = 2.344, 95% CI[.213, .25.733], p > .4). The odds of having low HDL increased by 
88% with every one-point increase on the Avoidance subscale of the CAQ (OR = 1.879, 
95% CI[.668, 5.289], p > .2).  
 
Model 5: Blood Pressure Adherence 
A hierarchical binomial logistic regression analysis was conducted to test marital 
status, general anxiety, CAQ fear, CAQ avoidance, and CAQ attention as predictors of 
blood pressure (0 = normal, 1 = high). Sixty-one participants provided data on the 
variables used in this analysis. Marital status added in the first step of the analysis; 
general anxiety (GAD-7 score) in the second; and CAQ fear, avoidance, and attention in 
the final step, as the variables of primary interest. Prior to analysis, we tested for outliers, 
multicollinearity, and the assumptions of logistic regression. No violations of 
multicollinearity or the assumptions of logistic regression were detected. One potential 
outlier was identified, but we decided to keep the participant in the data analysis due to 
the small sample size. Using G*Power 3.1 (Faul et al., 2009), power was excellent at 
0.89. Results of the analysis are shown in Table 8. 
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Table 8. Results of Hierarchal Logistic Regression Analyses Predicting Blood 
Pressure Non-Adherence  
 
     95% CI 
Predictor b SE OR p Lower Upper 
Marital Status -1.482 .62 .227 .017 .067 .767 
General Anxiety -.013 .08 .987 .868 .843 1.155 
Fear .477 .606 1.611 .432 .491 5.286 
Avoidance -.478 .303 .62 .115 .343 1.123 
Attention .087 .488 1.091 .858 .419 2.842 
Note: The reference group for this model is patients with normal BP. 
 
 
A test of the full model against a constant only model was not statistically 
significant, indicating that the predictors as a set did not reliably distinguish between 
those with normal and high BP, χ2(5) = 9.183, p > .05. In the final model, odds ratios 
indicated that there was a 77% decrease in the odds of having high BP if the participant 
was not married (OR = .227, 95% CI[.067, .767], p < .05). General anxiety was not a 
statistically or clinically significant predictor of BP (OR = .987, 95% CI[.843, 1.155], p > 
.8). None of the other predictors was statistically significant, but their effect sizes (ORs) 
were large enough to warrant interpretation. The odds of having high BP increased by 
61% with every one-point increase on the Fear subscale of the CAQ (OR = 1.611, 95% 
CI[.491, 5.286], p > .4). The odds of having high BP decreased by 38% with every one-
point increase on the Avoidance subscale of the CAQ (OR = .62, 95% CI[.343, 1.123], p 
> .1). The odds of having high BP increased by 9% with every one-point increase on the 
Attention subscale of the CAQ (OR = 1.091, 95% CI[.419, 2.842], p > .8). 
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CHAPTER FOUR 
DISCUSSION 
 
The purpose of the present study was to determine if heart-focused anxiety is a 
predictor of various forms of treatment adherence, and subsequently if it is a better 
predictor of adherence than general anxiety and other known predictors of treatment 
adherence. The results of each model predicting the five types of treatment adherence 
measures, including lifestyle recommendations, medication, LDL, HDL, and blood 
pressure, are discussed below.   
 
Adherence to Lifestyle Recommendations 
In this analysis, greater cardiac knowledge had a significant effect on increasing 
adherence to lifestyle recommendations. As previously reported, studies have found that 
more knowledge of the course and treatment of cardiac disease has a positive impact on 
adherence to recommended changes in diet and exercise (Alm-Roijer et al., 2004; van der 
Wal et al., 2005). Those with more knowledge about cardiac disease may feel more 
equipped to take care of themselves according to recommended guidelines. This model 
also showed that higher Positive Coping scores were associated with increased adherence 
to lifestyle recommendations. Positive coping includes coping styles such as planning, 
humor, acceptance, positive reframing, and active coping that lend well to making 
positive health changes to improve the course of the disease (de Ridder et al., 2009; 
Shepperd et al., 1996). Medication complexity, general anxiety, and the fear, avoidance, 
and attention subscales of the CAQ had no significant effect on adherence to lifestyle 
recommendations. While the variables were not each significant, the model as a whole 
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explained 23.5% of the variance of lifestyle adherence, suggesting that the combination 
of factors is more predictive than individual factors. Knowledge and positive coping 
accounted for 15.7% of the variance, and the other non-significant variables contributed 
another 7.8% of the variance of lifestyle recommendation adherence. 
Despite our small sample size, low power is an unlikely explanation for our null 
results. Power analyses for individual predictors indicated that we had 99% power to 
detect moderate and large effect sizes of .25 and .64, respectively, and greater than 40% 
power to detect a small effect size of at least .04 (Cohen et al., 2003). Effect sizes for all 
non-significant predictors were below the recommended minimum effect size of .04, 
suggesting that these predictors were both statistically and clinically non-significant 
(Ferguson, 2009). It is plausible that engaging in lifestyle choices is determined by other 
personal factors, such as knowledge seeking and active, solution-focused problem solving 
skills, as this model indicates. For example, in the current study knowledge was 
significantly and positively correlated with acceptance coping (r = .313, p < .05), which 
is a subscale of positive coping. This finding suggests that greater knowledge may 
improve positive coping, and together both may lead to better lifestyle adherence.  
Increased knowledge of CAD may also serve to reduce anxious thoughts and feelings 
about health (Khatib et al., 2014).   
 
Adherence to Prescribed Medications 
 In this model, panic, depression, and negative coping style each had no effect on 
participants’ adherence to their prescribed medications and together they only explained 
2% of the variance in medication adherence, which is inconsistent with prior research. 
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Research indicates that people with more negative emotional states, such as panic or 
depression, are more likely to use negative coping styles (Smedema et al., 2010). 
Consequently, positive coping styles such as action and planning coping, have been 
shown to have a positive impact on medication adherence (Lourenco, et al., 2013). 
Previous studies also indicate that higher levels of depression are associated with 
decreased medication adherence (DiMatteo, 2000). It was also found that, contrary to 
hypotheses, general anxiety and heart-focused anxiety had no impact on medication 
adherence. Higher levels of anxiety, both heart-focused and general, were expected to 
improve adherence to medications due to desire to avoid negative health consequences 
(DiMatteo, 2000).  
Despite our small sample size, low power is an unlikely explanation for our null 
results. Power analyses for individual predictors indicated that we had > 95% and 99% 
power to detect moderate and large effect sizes of .25 and .64, respectively, and 
approximately 40% power to detect a small effect size of at least .04 (Cohen et al., 2003). 
Effect sizes for all predictors were below the recommended minimum effect size of .04, 
suggesting that the predictors were both statistically and clinically non-significant 
(Ferguson, 2009). As previously mentioned, both the medication adherence measure and 
negative coping scale had poor reliability, which could potentially explain the lack of 
significance. It is possible the lack of significant results in this model is due to violations 
of the assumptions of the analysis, which are discussed below. It is also possible that 
depression, general anxiety, panic, negative coping, and heart-focused anxiety did not 
have effects on medication adherence because there are other more specific and important 
predictors we did not include in the analysis. For example, research has shown that the 
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strongest predictor of medication adherence is the patient’s understanding of the causes 
and effects of hypertension (Marshall et al., 2012). When patients are unaware of how 
hypertension functions, they are more likely to take their medication at a variable 
schedule. Fear of side effects of medications also plays a role in patients discontinuing 
their use of their medications (Marshall et al., 2012).  
 
LDL 
 In this study, men had 504% greater odds of having high or unhealthy LDL levels 
than women. LDL is considered the “bad” cholesterol, and is elevated by a diet high in 
saturated and trans fats (American Heart Association, 2016). Reducing LDL requires 
adherence to lifestyle recommendations, which is considered preventative treatment. 
Studies have shown that men and women utilize healthcare differently, and specifically 
that women are more adherent to recommendations and preventative treatments than men 
(Chung et al., 2006; Pinkhasov et al., 2010), which could explain this finding.  
Results of this model also indicate that every one-point increase in positive coping 
increased the odds of having unhealthy LDL by 10%. It is unclear why positive coping 
would have a negative effect on LDL cholesterol adherence, but given that this coping 
measure combines various types of coping, it could be that one of these types is driving 
this negative affect. Folkman and Moskowitz (2000) discuss the relationship among 
stress, positive emotion, and coping, especially in relation to chronic illness. The authors 
raise questions about the benefit and possible cost of positive coping style. For instance, 
problem-focused coping has been shown to only be effective if there is also a sense of 
control. While an individual may endorse using problem-focused or planning coping, if 
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he or she feels a lack of control over his or her illness, this type of coping may actually 
lead to feelings of hopelessness.  
Other questions are raised about how these positive coping styles interact in a 
chronic illness situation in which there may not be change. For many with a chronic 
illness, despite following all treatment recommendations, they may have to accept the 
fact that they will never be completely free of their condition. This realization may have 
an effect on the use of coping styles that is not yet known. The answer to questions such 
as these may offer insight as to why seemingly positive strategies contribute to negative 
health outcomes.  Alternatively, while most research equates positive coping with 
positive outcomes, it is possible that these positive coping skills may act as barriers to 
receiving new recommendations from health care professionals, if the patient believes she 
or he already utilizes positive skills and does not need additional advice. Consistent with 
this explanation, one study showed that those who already had the greatest amount of 
engagement in their healthcare showed the least improvement, which could speak to their 
sense of self-efficacy and possible non-reliance on health-care professionals (Hibbard & 
Greene, 2012). 
 General and heart-focused anxiety were not significant predictors of LDL 
cholesterol levels. However, recent research has indicated that interpreting effect sizes 
produces more clinically relevant information than null hypothesis testing alone due to 
the reliance of the latter on sample size (Nickerson, 2000; Rodgers, 2010). Therefore, the 
effect sizes of these variables will be discussed regarding practical or clinical 
significance. The effect size for general anxiety indicated that the odds of having 
unhealthy LDL increased by 13% for every one-point increase in general anxiety. 
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Previous research indicates that those with mood disorders, anxiety and/or depression, 
and those under stress are more likely to suffer from metabolic issues, such high LDL, 
due to poor diet choices (Davison & Kaplan, 2012), which may account for the present 
findings.  
For every one-point increase in the CAQ fear subscale, the odds of having 
unhealthy LDL increased by 26%. While there is no current research that explains this 
finding, it is possible that fear of adverse cardiac events could increase hopelessness and 
lead to poorer engagement in methods that might control LDL levels, such as weight loss 
and exercise. For every one-point increase in the CAQ avoidance subscale, the odds of 
having unhealthy LDL increased by 6%. Avoidance of activities that may cause a heart-
related event, such as exercise, would actually increase LDL levels; exercise is one of the 
recommendations to improve cholesterol according to the American Heart Association. It 
is also possible that avoidance of certain behaviors may generalize to avoidance of others, 
such as healthy eating, which is another recommendation to control LDL.  
For every one-point increase in the CAQ attention subscale, the odds of having 
unhealthy LDL decreased by 79%. It is feasible that increased attention to the heart and 
its sensations would make an individual more likely to regularly monitor outcome 
measures, such as cholesterol, to keep them in a healthy range. Research confirms that 
patients who are more engaged in their healthcare, including active monitoring, and are 
not just simply compliant have more positive health outcomes (Hibbard & Greene, 2012). 
Both fear and attention had a greater impact on LDL levels than general anxiety, 
indicating that these subscales of heart-focused anxiety are better at explaining adherence 
to LDL levels than general anxiety alone.  
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HDL 
 None of the predictors of this model was statistically significant; however, their 
effect sizes will be discussed in relation to practical or clinical significance. In this model, 
for every one-point increase in negative coping, there was a 5.7% decrease in the odds of 
having low or unhealthy HDL levels. Contrary to research that states negative coping 
styles are associated with poorer health outcomes, this finding indicates that negative 
coping actually leads to better HDL levels. There does not appear to be a clear answer in 
the literature regarding the positive effect of coping; however, one possible explanation 
could be that self-distraction, a subscale of negative coping, may include behaviors that 
are beneficial to health outcomes. For example, patients may be encouraged to take a 
walk, garden, or use exercise as a positive way to distract, improve mood, and reduce 
stress. If patients are using strategies such as these, the physical exercise would have a 
positive effect on their cholesterol. 
For every one-point increase in general anxiety, there was a 56.3% decrease in the 
odds of having low or unhealthy HDL levels. Previous research has found that increases 
in anxiety are associated with reduced HDL levels, which creates increased risk of 
cardiovascular disease (van Reedt Dortland et al., 2013). As a reminder, HDL is a good 
form of cholesterol that removes LDL, the “bad” cholesterol, from the blood stream. 
Increasing HDL involves adding healthy fats into the diet, along with exercising and 
removing unhealthy fats. It is possible that for participants in this study, as previously 
mentioned, increased general anxiety may promote positive health behaviors, such as 
proper diet and exercise, for fear of having a future cardiac event (DiMatteo, 2000).  
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The odds of having low or unhealthy HDL increased by 134% and 88% for every 
one-point increase in the fear and avoidance subscales of the CAQ, respectively. 
Theoretically, fear of a cardiac event could be followed by avoidance of activities that are 
believed to lead to a cardiac event, such as exercise or physical work. Avoidance of 
activities thought to cause a cardiac event could impact HDL, given that exercise is an 
activity commonly avoided by those with high avoidance scores, and exercise is shown to 
increase HDL (Pattyn et al., 2012).  
For every one-point increase in CAQ attention, there was a 1% increase in the 
odds of having low or unhealthy HDL levels. This effect is both statistically and 
clinically non-significant. Attention may not have an effect on HDL cholesterol because 
it assesses an individual’s preoccupation with his or her heart and its sensations. HDL is 
tested by blood draws and therefore would be not be something patients would be able to 
readily monitor by attending to sensations such as their pulse. Both the fear and 
avoidance subscales of heart-focused anxiety had a larger effect on HDL than general 
anxiety alone, but the attention subscale did not.  
 
Blood Pressure 
In this model, marital status had a significant impact on blood pressure. 
Participants who identified as not married had a 77% decrease in the chances of having 
high BP than their married counterparts. Research has indicated that the health benefits of 
marriage mostly apply to men, showing that in patients with a chronic illness, married 
men are subject to more social influence and control of critical health behaviors, such as 
diet, from their spouses than married women and unmarried individuals (August & 
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Sorkin, 2010). While this sample is mostly female by a slight margin, gender effects 
could help to explain this finding. No other variables were statistically significant 
predictors of blood pressure; however, effect sizes will be discussed in terms of practical 
and clinical significance. For every one-point increase in general anxiety, the odds of 
having high blood pressure increased by 1%, making it both statistically and clinically 
non-significant. In a review of studies examining the effect of general anxiety and 
cardiovascular health, it was found that general anxiety had no significant relationship 
with markers of CAD, such as blood pressure, in patients with established diagnoses 
(Tully et al., 2013). The authors found that the prevalence of general anxiety in the 
cardiac population was less significant than other psychological factors, such as 
depression, and that factors such as worry may be more predictive of development of 
CAD.   
For every one-point increase in CAQ fear, the odds of having high blood pressure 
increased by 61%. Fear of a cardiac event may be elevating the odds of high blood 
pressure due to the very nature of anxiety. It is possible that a specific fear, in this case 
fear of a heart-related event, is modulated by areas in the brain that produce a stronger 
stress response in the body, including higher blood pressure, and is therefore more 
intense than generalized anxiety (McEwen, 2004). This could account for fear’s large 
effect size in determining blood pressure. For every one-point increase in CAQ 
avoidance, the odds of having high blood pressure decreased by 38%. One possible 
explanation is that avoidance of activities thought to induce a cardiac event may be 
limited to avoiding physical activity, but it does not account for other behaviors that may 
be seen as likely to prevent a future cardiac event, such as taking medications to control 
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blood pressure. For every one-point increase in CAQ attention, the odds of having high 
blood pressure increased by 9%. Increased attention to the heart and its sensations may 
make an individual more attuned to his or her heart rate and cause anxiety and fear about 
those sensations, thus increasing blood pressure (Player & Peterson, 2011).  
As hypothesized, heart-focused fear, avoidance, and attention were stronger 
predictors of blood pressure levels than general anxiety. This could be due to the 
biological processes that link anxiety to CAD, such as increased activation of the 
sympathetic nervous system, which involves increased heart rate, constricted blood 
vessels and increased blood pressure (Thurston et al., 2013). Given that heart-focused 
anxiety is a more specific measure of anxiety, it is possibly a more tangible measure of 
anxiety for the cardiac population. As a result of this greater specificity, when elicited, 
heart-focused anxiety may produce a stronger biological response in the body than 
general anxiety alone.   
 
Implications 
 Based the effect sizes from the present analyses, the practical and clinical 
significance our findings may add to the clinical understanding of anxiety and cardiac 
disease, and can be used to facilitate future research. Previous research has demonstrated 
that the effect of anxiety on cardiac disease is variable. In this study, heart-focused 
anxiety did not significantly predict the adherence measures in this study, possibly due to 
the limitations discussed below. However, in many instances, fear, avoidance, and/or 
attention subscales of heart-focused anxiety did have greater predictive power on the 
adherence measures than general anxiety when taking effect sizes into account. What this 
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implies is that heart-focused anxiety, and specifically the CAQ measure, may be a better 
predictor of treatment adherence and thus outcomes, than general anxiety alone. 
Clinically, these findings may be used to encourage health care professionals to ask more 
pointed and specific questions about their cardiac patients’ anxiety, especially in relation 
to their disease, and to ask how their anxiety may be impacting their ability to engage in 
treatment. The CAQ is a quick measure that is easily scored and can be used in a high-
volume clinical environment to assess a patient’s heart-focused anxiety.  Future research 
can examine the present factors studied here, as well as differentiate among the various 
types of anxiety, such as general, panic, and trait, that were unable to be assessed in the 
present study. It may be most useful to examine all of these factors in a large study using 
a structural equation model approach (e.g., cross-lagged panel models) to test 
bidirectional relationships among these variables over time.  
 Across all models, fear-related anxiety was associated with increased odds of non-
adherence. It may be useful to study the effects of including treatment for cardiac-related 
fear in behavioral interventions for cardiac patients, or as part of cardiac rehabilitation. 
Possible interventions for those experiencing fear related to their cardiac condition could 
include increased education about treatment and course of the disease, as well as 
psychological interventions such as Cognitive Behavioral Therapy for Anxiety, 
specifically in relation to their fear of a cardiac event. Relaxation training can also be 
utilized in behavioral interventions for reducing stress, heart rate, and blood pressure. 
Research has found that relaxation, and specifically mindfulness-based stress reduction, 
is an effective tool at reducing stress, cortisol levels, and blood pressure in patients with 
chronic illnesses (Carlson et al., 2007), and that the use of relaxation techniques is 
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associated with healthy lifestyle habits such as regular exercise (Lee & Yeo, 2013). As 
demonstrated here and in previous research, those with increased knowledge demonstrate 
higher levels of adherence to lifestyle recommendations (Alm-Roijer et al., 2004; van der 
Wal et al., 2005).  
Attention to heart sensations and avoidance of activities thought to cause a cardiac 
event had variable effects on adherence measures, at times improving and at other times 
harming the chances of adherence. Avoidance of activities was shown to be harmful to 
LDL and HDL levels, while it was helpful for blood pressure adherence, and had no 
effect on lifestyle or medication adherence. Attention to heart sensations was harmful to 
HDL and blood pressure, beneficial to LDL levels, and had no effect on lifestyle or 
medication adherence. Future research should focus on attention and avoidance factors to 
determine if they are posing barriers to treatment, as well if they are correlated with other 
known barriers to treatment to develop more clear treatment recommendations for those 
experiencing increased attention and avoidance.   
Regarding other known predictors, knowledge and positive coping significantly 
predicted improved adherence to lifestyle recommendations. Encouraging and training 
patients to use positive coping skills, as well as providing increased education are 
potentially useful interventions to promote adherence. Specifically, patients should be 
educated about the course of CAD and the known preventative and treatment measures, 
such as diet and exercise. Studies have shown that knowledge is the most influential 
factor in improving adherence (Khatib et al., 2014). Additionally, studies have found that 
patients often believe their blood pressure is only elevated during times of emotional 
stress, and educating them about the chronic nature of blood pressure elevation can 
 58 
change how they treat hypertension and adherence to medications (Marshall et al., 2012). 
Being male and positive coping significantly predicted unhealthy LDL cholesterol levels, 
indicating that men may need more counseling about their cholesterol levels and what 
contributes to them, such as eating unhealthy versus healthy fats. It would also be 
beneficial for healthcare providers to talk more openly about their patients’ understanding 
of their cholesterol and necessary medications, eliciting any misinformation and/or fears 
that can be discussed. Future studies could examine if developing a short measure to 
assess common barriers to treatment and then addressing these barriers in a clinical 
setting would improve treatment adherence and outcomes.  
Lastly, being unmarried significantly predicted lower blood pressure, indicating 
there is may be an unidentified barrier to adherence for married patients, such as lack of 
spousal knowledge or unhealthy lifestyle choices of the spouse, or that marriage is related 
to higher blood pressure in this population via some other mechanism, such as increased 
relationship stress due to the CAD diagnosis and its treatment. More research in this area 
would help to clarify the role of marriage and CAD risk factors. Patients who are married 
may benefit from having their spouse present during appointments to determine if there 
are other factors inhibiting successful treatment adherence. Physicians can begin this 
discussion with their patients and make referrals to health psychologists to help patients 
involve their spouses in their care. Research has shown that when spouses are actively 
involved in care, patients are more adherent to treatment and have better health outcomes 
(Sayers et. al, 2008). Lifestyle changes are easier when a spouse is supporting change in 
diet and exercise, as well as reminding patients of medications and medical appointments.  
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Limitations 
The present study had several limitations that affect the interpretation of the 
results. The present study had a small sample size, and therefore we could not include all 
of the potential predictors that we originally proposed to test. Future studies with larger 
sample sizes are required to test all relevant predictors of treatment adherence in cardiac 
patients simultaneously. This may also allow for better generalizability of the results, as a 
larger sample would be more representative of the population. In addition, this study was 
cross-sectional in design, and thus casual inferences could not be made. In the future, it 
would be beneficial to use a longitudinal design to study the effects over time. Next, the 
sample was largely Caucasian. Future studies should include a more diverse sample to 
test for potential racial and/or ethnic differences in adherence to treatment 
recommendations and potential differences in which factors affect adherence. In addition, 
the models predicting lifestyle and medication adherence violated the statistical 
assumptions of normality and homoscedasticity. Transformations of the dependent 
variables were conducted to correct for these violations; however, the transformations did 
not correct for violations in the medication adherence model. Therefore, the results of this 
analysis are likely to be biased in that the regression coefficients and standard errors may 
be too small or too large, thus potentially invalidating the results of any hypothesis tests. 
Also, poor reliability for the negative coping and medication adherence variables could 
have contributed to any non-significant findings, including preliminary analyses used to 
decide which variables would be included in which analyses. Also of note, self-report 
data were collected from up to 72% of participants for blood pressure, 28% for LDL, and 
29% for HDL, which may impact the findings as patients may underreport their readings, 
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since some studies show that people may have a tendency to underreport these numbers 
(Mengden et al., 1998). Finally, there may be self-selection bias limiting this study, 
because participants volunteered to enroll in the study, which may indicate these people 
may be different from those who declined to participate (e.g., they may be more likely to 
engage in treatment and therefore not as distressed by their condition).  
 
Conclusion 
 In summary, the findings of the present study could help identify predictors of 
cardiac treatment adherence, if replicated with a larger sample size. Heart-focused 
anxiety and its subscales may offer more specific information related to a patient’s 
experience of the course of his or her cardiac disease. Given that most of the CAQ 
subscales had a larger impact on predicting treatment adherence than general anxiety, it is 
important to further study heart-focused anxiety as potential predictor of patient 
adherence and possibly treatment outcome. Future research can examine how various 
factors, such as gender, ethnicity, stress, panic disorder, social support, and coping, 
interact with each other and heart-focused anxiety to impact a patient’s adherence. Such 
studies can lead to better identification of those at risk of non-adherence, as well as lead 
to clearer and timelier identification of psychological interventions, and improving 
patient quality of life and outcomes.  
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APPENDIX A 
GENERALIZED ANXIETY DISORDER 7 
 
 
Over the last 2 weeks, how often have 
you been bothered by any of the 
following problems? 
(circle the best answer) 
 
Not at 
all 
Several 
days 
More than 
half the 
days 
Nearly 
every day 
1. Feeling nervous, anxious, or on edge 0 1 2 3 
2. Not being able to stop or control 
worrying 
0 1 2 3 
3. Worrying too much about different 
things 
0 1 2 3 
4. Trouble relaxing 0 1 2 3 
5. Being so restless that it is hard to sit 
still 
0 1 2 3 
6. Becoming easily annoyed or irritable 0 1 2 3 
7. Feeling afraid as if something awful 
might happen 
0 1 2 3 
8.  If you checked off any problems, how 
difficult have these problems made it for 
you to do your work, take care of things at 
home, or get along with other people? 
0 1 2 3 
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APPENDIX B 
 
STAI- TRAIT INVENTORY 
 
A number of statements which people have used to describe themselves 
are given below. Read each statement and then circle the appropriate 
number to the right of the statement to indicate how you generally feel. 
A
lm
o
st N
ev
er 
S
o
m
etim
es 
O
ften
 
A
lm
o
st A
lw
ay
s 
21. I feel pleasant………………………………………………………… 1 2 3 4 
22. I feel nervous and restless……………………………………………. 1 2 3 4 
23. I feel satisfied with myself…………………………………………… 1 2 3 4 
24. I wish I could be as happy as others seem to be……………………... 1 2 3 4 
25. I feel like a failure……………………………………………………. 1 2 3 4 
26. I feel rested…………………………………………………………... 1 2 3 4 
27. I am “calm, cool, and collected”……………………………………... 1 2 3 4 
28. I feel that difficulties are piling up so that I cannot overcome them… 1 2 3 4 
29. I worry too much over something that doesn’t really matter………... 1 2 3 4 
30. I am happy…………………………………………………………… 1 2 3 4 
31. I have disturbing thoughts…………………………………………… 1 2 3 4 
32. I lack self-confidence………………………………………………… 1 2 3 4 
33. I feel secure…………………………………………………………... 1 2 3 4 
34. I make decisions easily………………………………………………. 1 2 3 4 
35. I feel inadequate……………………………………………………… 1 2 3 4 
36. I am content………………………………………………………….. 1 2 3 4 
37. Some unimportant thought runs through my mind and bothers me…. 1 2 3 4 
38. I take disappointments so keenly that I can’t put them out of my 
mind………………………………………………………………………. 1 2 3 4 
39. I am a steady person………………………………………………….. 1 2 3 4 
40. I get in a state of tension or turmoil as I think over my recent 
concerns and interests …………………………………………………… 1 2 3 4 
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APPENDIX C 
 
PANIC DISORDER SEVERITY SCALE – SELF-REPORT FORM 
 
Several of the following questions refer to panic attacks and limited symptom attacks. For 
this questionnaire we define a panic attack as a sudden rush of fear or discomfort 
accompanied by at least 4 of the symptoms listed below. In order to qualify as a sudden 
rush, the symptoms must peak within 10 minutes. Episodes like panic attacks but having 
fewer than 4 of the listed symptoms are called limited symptom attacks. Here are the 
symptoms to count: 
 
• Rapid or pounding heartbeat    
• Sweating    
• Trembling or shaking  
• Breathlessness 
• Feeling of choking    
• Chest pain or discomfort    
• Nausea     
• Dizziness or faintness    
• Feelings of unreality   
• Numbness or tingling  
• Chills or hot flushes    
• Fear of losing control or going crazy    
• Fear of dying 
 
1. How many panic and limited symptoms attacks did you have during the week? 
 0 No panic or limited symptom episodes  
 1 Mild: no full panic attacks and no more than 1 limited symptom attack/day  
 2 Moderate: 1 or 2 full panic attacks and/or multiple limited symptom    
                   attacks/day  
 3 Severe: more than 2 full attacks but not more than 1/day on average  
 4 Extreme: full panic attacks occurred more than once a day, more days than  
                   not 
 
2. If you had any panic attacks during the past week, how distressing (uncomfortable, 
frightening) were they while they were happening? (If you had more than one, give an 
average rating. If you didn’t have any panic attacks but did have limited symptom 
attacks, answer for the limited symptom attacks.) 
 0 Not at all distressing, or no panic or limited symptom attacks during the past  
                   week  
 1 Mildly distressing (not too intense)  
 2 Moderately distressing (intense, but still manageable)  
 3 Severely distressing (very intense) 
 4 Extremely distressing (extreme distress during all attacks) 
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3. During the past week, how much have you worried or felt anxious about when your 
next panic attack would occur or about fears related to the attacks (for example, that they 
could mean you have physical or mental health problems or could cause you social 
embarrassment)? 
 0 Not at all  
 1 Occasionally or only mildly  
 2 Frequently or moderately  
 3 Very often or to a very disturbing degree  
 4 Nearly constantly and to a disabling extent 
 
4. During the past week were there any places or situations (e.g., public transportation, 
movie theaters, crowds, bridges, tunnels, shopping malls, being alone) you avoided, or 
felt afraid of (uncomfortable in, wanted to avoid or leave), because of fear of having a 
panic attack? Are there any other situations that you would have avoided or been afraid 
of if they had come up during the week, for the same reason? If yes to either question, 
please rate your level of fear and avoidance this past week. 
 0 None: no fear or avoidance  
 1 Mild: occasional fear and/or avoidance but I could usually confront or endure 
the situation. There was little or no modification of my lifestyle due to this.  
 2 Moderate: noticeable fear and/or avoidance but still manageable. I avoided 
some situations, but I could confront them with a companion. There was some 
modification of my lifestyle because of this, but my overall functioning was 
not impaired.  
 3 Severe: extensive avoidance. Substantial modification of my lifestyle was 
required to accommodate the avoidance making it difficult to manage usual 
activities.  
 4 Extreme: pervasive disabling fear and/or avoidance. Extensive modification 
in my lifestyle was required such that important tasks were not performed. 
 
5. During the past week, were there any activities (e.g., physical exertion, sexual 
relations, taking a hot shower or bath, drinking coffee, watching an exciting or scary 
movie) that you avoided, or felt afraid of (uncomfortable doing, wanted to avoid or stop), 
because they caused physical sensations like those you feel during panic attacks or that 
you were afraid might trigger a panic attack? Are there any other activities that you 
would have avoided or been afraid of if they had come up during the week for that 
reason? If yes to either question, please rate your level of fear and avoidance of those 
activities this past week. 
 0 No fear or avoidance of situations or activities because of distressing physical  
  sensations  
 1 Mild: occasional fear and/or avoidance, but usually I could confront or endure 
with little distress activities that cause physical sensations. There was little 
modification of my lifestyle due to this.  
 2 Moderate: noticeable avoidance but still manageable. There was definite, but 
limited, modification of my lifestyle such that my overall functioning was not 
impaired.  
 3 Severe: extensive avoidance. There was substantial modification of my 
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lifestyle or interference in my functioning.  
 4 Extreme: pervasive and disabling avoidance. There was extensive 
modification in my lifestyle due to this such that important tasks or activities 
were not performed. 
 
 
6. During the past week, how much did the above symptoms altogether (panic and 
limited symptom attacks, worry about attacks, and fear of situations and activities 
because of attacks) interfere with your ability to work or carry out your responsibilities at 
home? (If your work or home responsibilities were less than usual this past week, 
answer how you think you would have done if the responsibilities had been usual.) 
 0 No interference with work or home responsibilities  
 1 Slight interference with work or home responsibilities, but I could do nearly 
everything I could if I didn’t have these problems.  
 2 Significant interference with work or home responsibilities, but I still could 
manage to do the things I needed to do.  
 3 Substantial impairment in work or home responsibilities; there were many 
important things I couldn’t do because of these problems.   
 4 Extreme, incapacitating impairment such that I was essentially unable to 
manage any work or home responsibilities. 
 
7. During the past week, how much did panic and limited symptom attacks, worry 
about attacks and fear of situations and activities because of attacks interfere with your 
social life? (If you didn’t have many opportunities to socialize this past week, answer 
how you think you would have done if you did have opportunities.) 
  0 No interference  
  1 Slight interference with social activities, but I could do nearly everything I 
could if I didn’t have these problems.  
  2 Significant interference with social activities but I could manage to do most 
things if I made the effort.  
  3 Substantial impairment in social activities; there are many social things I 
couldn’t do because of these problems. 
           4      Extreme, incapacitating impairment, such that there was hardly anything  
       social could do.  
 
 
 
 
 
 
 
 
 75 
APPENDIX D 
 
CARDIAC ANXIETY QUESTIONNAIRE 
 
Please rate each item by circling the answer (number) that best applies to you:   
 Never  Rarely  Sometimes Often Always  
1. I pay attention to my heart beat 0 1 2 3 4 
2. I avoid physical exertion 0 1 2 3 4 
3. My racing heart wakes me up at 
night 
0 1 2 3 4 
4. Chest pain/discomfort wakes me 
up at night  
0 1 2 3 4 
5. I take it easy as much as possible  0 1 2 3 4 
6. I check my pulse 0 1 2 3 4 
7. I avoid exercise or other physical 
work  
0 1 2 3 4 
8. I can feel my heart in my chest  0 1 2 3 4 
9. I avoid activities that make my 
heart beat faster 
0 1 2 3 4 
10. If tests come out normal, I still 
worry about my heart 
0 1 2 3 4 
11. I feel safe being around a 
hospital, physician or other medical 
facility 
0 1 2 3 4 
12. I avoid activities that make me 
sweat 
0 1 2 3 4 
13. I worry that doctors do not 
believe my symptoms are real 
0 1 2 3 4 
      
When I have chest discomfort or when my heart is beating fast:  
14. I worry that I may have a heart 
attack  
0 1 2 3 4 
15. I have difficulty concentrating on 
anything else  
0 1 2 3 4 
16. I get frightened  0 1 2 3 4 
17. I like to be checked out by a 
doctor  
0 1 2 3 4 
18. I tell my family or friends  0 1 2 3 4 
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APPENDIX E 
 
CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE 
 
For each statement, please place a mark in the column that best describes how you have 
been feeling in the past week. 
 
 
 Rarely or 
none of the 
time 
(less than 1 
day) 
Some or a 
little of the 
time 
(1 – 2 days) 
Occasionally 
or a moderate 
amount of 
the time 
(3 – 4 days) 
Most or 
all of the 
time 
(5 – 7 
days) 
1. I was bothered by things that 
usually don’t bother me. 
 
 
 
 
 
 
 
 
2. I did not feel like eating; my 
appetite was poor. 
 
 
 
 
 
 
 
 
3. I felt that I could not shake off the 
blues, even with the help from family 
or friends. 
 
 
 
 
 
 
 
 
 
 
 
 
4. I felt that I was just as good as 
other people. 
    
5. I had trouble keeping my mind on 
what I was doing. 
    
6. I felt depressed.     
7. I felt that everything I did was an 
effort. 
    
8. I felt hopeful about the future.     
9. I thought my life had been a 
failure. 
    
10. I felt fearful.     
11. My sleep was restless.     
12. I was happy.     
13. I talked less than usual.     
14. I felt lonely.     
15. People were unfriendly.     
16. I enjoyed life.     
17. I had crying spells.     
18. I felt sad.     
19. I felt that people dislike me.     
20. I could not get “going”.     
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APPENDIX F 
 
CADE-Q KNOWLEDGE 
 
1. Coronary Artery Disease (CAD) is:  
o A disease of the arteries of the heart which occurs in older age in people with high 
cholesterol and who smoke.  
o A disease of the arteries of the heart that starts silently at a young age, is 
influenced by poor life style habits, has a genetic component, and involves 
inflammation in the arteries.  
o A disease of the heart’s arteries related to older age and that leads to memory 
Impairment.  
o I don’t know.  
 
2. Which factors have the most influence on the risk of heart attack?  
o Drinking small amounts of alcoholic beverages.  
o Environment factors (such as weather) and socioeconomic factors (such as 
monthly family income).  
o Smoking, high levels of blood cholesterol (dyslipidemia), and hypertension (high 
blood pressure).  
o I don’t know.  
 
3. Which description below is a typical symptom of CAD?  
o Headache after meals. 
o Chest pain or discomfort during physical activity.  
o Chest pain or discomfort, at rest or during physical activity, which can also be felt 
in the arm and/or back and/or neck.  
o I don’t know.  
 
4. Which of the following statements is most accurate regarding our understanding of 
CAD?  
o CAD is related to blockage of the arteries that supply blood to the heart caused by 
the formation of atherosclerotic plaques (fat deposit on the arteries’ walls), that 
can cause angina (chest pain).  
o Acute Myocardial Infarction (MI or heart attack) is the only manifestation of 
CAD.  
o The presence of chest pain is suggestive of a diagnosis of CAD. 
o I don’t know.  
 
5. The best time of the day for people with coronary disease to carry out their prescribed 
exercise is:  
o In the afternoon or evening, because the early morning is the time of day with the 
highest risk of a heart attack.  
o Never, because exercise is considered too risky for people with CAD. 
o Any time, because the benefits of exercise outweigh the risks at any time of day.  
o I don’t know.  
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6. Of the investigations listed below, which ones provide the most precise information 
about the diagnosis and prognosis of CAD?  
o X-Ray and Magnetic Resonance Imaging of the chest. 
o Exercise Treadmill Test (Stress test) and cardiac catheterization (angiogram).  
o Electrocardiogram (EKG) at rest and a clinical history. 
o I don’t know.  
  
7. Which of the following statements about the management of blood cholesterol levels is 
most accurate?  
o Physical exercise and diet are enough to lower cholesterol to target levels after a 
heart attack.  
o Physical exercise and diet should be followed regularly and when necessary, a 
medication such as a “statin” may be required  
o There is no treatment because high cholesterol levels are genetically inherited and 
can’t be changed.  
o I don’t know.  
 
8. Which of the following statements about the use of “nitroglycerin” is most accurate?  
o They are a class of medications that can be administered to improve coronary 
blood flow and can be given either continuously (such as in a tablet or patch) or 
used sublingually (under the tongue as a spray or small tablet) in situations of 
acute chest pain.  
o They are medications given only by the sublingual route in emergency situations 
to relieve chest pain.  
o They are medicines used to decrease blood pressure and bad cholesterol (LDL) in 
patients with cardiac problems.  
o I don’t know.  
 
9. Which of the following dietary components best describes a nutritional plan for 
persons with CAD?  
o A diet with reduced salt, low fat and rich in fiber. 
o A diet based on whole grains, vegetables, fish, extra virgin olive oil and nuts.  
o An unrestricted diet, because diet is not a relevant factor. 
o I don’t know.  
 
10. Which values for LDL cholesterol and HDL cholesterol are the optimal targets 
persons with established CAD (values in mmol/litre)?  
o LDL less than 2.0 and HDL greater than 1.2.  
o LDL 2.0 to 2.5 and HDL greater than 1.0. 
o LDL greater than 3.0 and HDL less than 1.0.  
o I don’t know.  
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11. In which of the following situations would you avoid carrying out your regular 
physical exercise?  
o If you had a recent heart attack (for example 8 weeks ago). 
o If you have a bad infection today (for example a really bad “flu”). 
o If your blood pressure is moderately elevated (for example 150/90).  
o I don’t know.  
 
12. While walking, if you experience a new episode of severe chest discomfort that you 
think that is angina, you should:  
o Drive your car directly to the hospital to seek medical care. 
o Try to relax, wait for the pain to improve, and then seek medical attention.  
o Stop your walk and sit, take a sublingual nitroglycerin, and seek medical care if 
the pain does not subside. Call your doctor to let him or her know what has 
happened.  
o I don’t know.  
 
13. Based on your knowledge about exercise and CAD, choose the most appropriate 
statement below:  
o Physical exercise should never be practiced by patients with coronary artery 
disease because of high risk of death.  
o Physical exercise is a fundamental part of the treatment plan, because it helps to 
control risk factors, prolongs survival and enhances quality of life.  
o Physical activity should be included in the treatment plan only when patients are 
fully recovered from their heart event.  
o I don’t know.  
 
14. Guidelines for Physical Activity for people with coronary disease should be based 
upon which of the following:  
o The exercise prescription should be individually devised based on an exercise 
stress test and respect the person’s abilities and disabilities.  
o Start at a low level to moderate level and build up gradually.  
o Be the same for all persons of the same gender and age, because these groups 
have the same physical ability and risk.  
o I don’t know.  
 
15. Which of the following changes in the body resulting from regular physical exercise 
are most important to long term cardiac health?  
o Blood vessel function improvement, growth of new blood vessels, and even a 
possible regression (shrinking) of atherosclerotic plaque.  
o Resting heart rate decrease, more forceful heart beat, and lipid profile 
improvement.  
o Blood Pressure increase, higher heart rates, and higher triglyceride levels.  
o I don’t know.  
 
16. Which of the following statements best describes the pattern for exercise activity in 
persons recovering from a heart event:  
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o At any place, daily duration of about 30 minutes, which can be cumulative (10 
min at morning, 10 min at noon and 10 min at night).  
o In an appropriate setting, with periodic monitoring by qualified professionals, 
with the goal of achievement of self-sufficiency.  
o In a hospital environment only.  
o I don’t know.  
 
17. Which of the following statements is the most appropriate guidance around levels of 
blood pressure levels in persons with CAD:  
o It doesn’t matter whether blood pressure is normal or high because it does not 
have any long-term health effects.  
o A value of less than 140 / 90 mmHg is considered normal.  
o An optimal blood pressure is 120 / 80 mmHg. 
o I don’t know.  
 
18. Which of the statements below regarding psychological stress is most correct?  
o It is one of the important risk factors for AMI (Acute Myocardial Infarction or 
heart attack).  
o Stress is related to the presence of anxiety and depression.  
o It has no impact on heart disease, since atherosclerosis is a completely physical 
process and is not related to psychological factors.  
o I don’t know.  
 
19. Which interventions can extend and improve a patient’s quality of life for persons 
recovering from a cardiac event?  
o Lifestyle changes + medical treatments + in some cases surgical intervention.  
o Medication + in some cases surgical intervention.  
o Prolonged bed rest.  
o I don’t know.  
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APPENDIX G 
 
PERCEIVED STRESS SCALE 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you felt or 
thought a certain way.  
 
 Never  Rarely  Sometimes Often Always  
1. In the last month, how often have 
you been upset because of something 
that happened unexpectedly? 
0 1 2 3 4 
2. In the last month, how often have 
you felt that you were unable to 
control the important things in your 
life? 
0 1 2 3 4 
3. In the last month, how often have 
you felt nervous and “stressed”? 
0 1 2 3 4 
4. In the last month, how often have 
you felt confident about your ability 
to handle your personal problems?  
0 1 2 3 4 
5. In the last month, how often have 
you felt that things were going your 
way? 
0 1 2 3 4 
6. In the last month, how often have 
you found that you could not cope 
with all the things that you had to do?  
0 1 2 3 4 
7.  In the last month, how often have 
you been able to control irritations in 
your life?  
0 1 2 3 4 
8. In the last month, how often have 
you felt that you were on top of 
things? 
0 1 2 3 4 
9. In the last month, how often have 
you been angered because of things 
that were outside of your control? 
0 1 2 3 4 
10. In the last month, how often have 
you felt difficulties were piling up so 
high that you could not overcome 
them?  
0 1 2 3 4 
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APPENDIX H 
 
MULTIDIMENSIONAL SCALE OF PERCEIVED SOCIAL SUPPORT (ZIMET, 
DAHLEM, ZIMET & FARLEY, 1988) 
 
Instructions: We are interested in how you feel about the following statements. Read each 
statement carefully.  
Indicate how you feel about each statement. 
Circle the “1” if you Very Strongly Disagree  
Circle the “2” if you Strongly Disagree  
Circle the “3” if you Mildly Disagree 
Circle the “4” if you are Neutral 
Circle the “5” if you Mildly Agree 
Circle the “6” if you Strongly Agree  
Circle the “7” if you Very Strongly Agree 
 
 
1. There is a special person who is around when I am in 
need.  
1 2 3 4 5 6 7 
2. There is a special person with whom I can share my 
joys and sorrows.  
1 2 3 4 5 6 7 
3. My family really tries to help me.  1 2 3 4 5 6 7 
4. I get the emotional help and support I need from my 
family.  
1 2 3 4 5 6 7 
5. I have a special person who is a real source of comfort 
to me.  
1 2 3 4 5 6 7 
6. My friends really try to help me.  1 2 3 4 5 6 7 
7. I can count on my friends when things go wrong.  1 2 3 4 5 6 7 
8. I can talk about my problems with my family.  1 2 3 4 5 6 7 
9. I have friends with whom I can share my joys and 
sorrows.  
1 2 3 4 5 6 7 
10. There is a special person in my life who cares about 
my feelings.  
1 2 3 4 5 6 7 
11. My family is willing to help me make decisions.  1 2 3 4 5 6 7 
12. I can talk about my problems with my friends.  1 2 3 4 5 6 7 
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APPENDIX I 
 
BRIEF COPE 
These items deal with ways you've been coping with the stress in your life since you 
found out you have a cardiac diagnosis. There are many ways to try to deal with 
problems.  These items ask what you've been doing to cope with this one.  Obviously, 
different people deal with things in different ways, but I'm interested in how you've tried 
to deal with it.  Each item says something about a particular way of coping.  I want to 
know to what extent you've been doing what the item says.  How much or how 
frequently.  Don't answer on the basis of whether it seems to be working or not—just 
whether or not you're doing it.  Use these response choices.  Try to rate each item 
separately in your mind from the others.  Make your answers as true FOR YOU as you 
can. 
1 = I haven't been doing this at all 
2 = I've been doing this a little bit  
3 = I've been doing this a medium amount  
4 = I've been doing this a lot 
 
1.  I've been turning to work or other activities to take my mind 
off things. 1 2 3 4 
2.  I've been concentrating my efforts on doing something about 
the situation I'm in.  1 2 3 4 
3.  I've been saying to myself "this isn't real.".  1 2 3 4 
4.  I've been using alcohol or other drugs to make myself feel 
better.  1 2 3 4 
5.  I've been getting emotional support from others.  1 2 3 4 
6.  I've been giving up trying to deal with it.  1 2 3 4 
7.  I've been taking action to try to make the situation better.  1 2 3 4 
8.  I've been refusing to believe that it has happened.  1 2 3 4 
9.  I've been saying things to let my unpleasant feelings escape.  1 2 3 4 
10.  I’ve been getting help and advice from other people.  1 2 3 4 
11.  I've been using alcohol or other drugs to help me get through 
it.  1 2 3 4 
12.  I've been trying to see it in a different light, to make it seem 
more positive.  1 2 3 4 
13.  I’ve been criticizing myself.  1 2 3 4 
14.  I've been trying to come up with a strategy about what to do.  1 2 3 4 
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15.  I've been getting comfort and understanding from someone.  1 2 3 4 
16.  I've been giving up the attempt to cope.  1 2 3 4 
17.  I've been looking for something good in what is happening.  1 2 3 4 
18.  I've been making jokes about it.  1 2 3 4 
19.  I've been doing something to think about it less, such as 
going to movies, watching TV, reading, daydreaming, sleeping, 
or shopping. 1 2 3 4 
20.  I've been accepting the reality of the fact that it has happened.  1 2 3 4 
21.  I've been expressing my negative feelings.  1 2 3 4 
22.  I've been trying to find comfort in my religion or spiritual 
beliefs.  1 2 3 4 
23.  I’ve been trying to get advice or help from other people about 
what to do.  1 2 3 4 
24.  I've been learning to live with it.  1 2 3 4 
25.  I've been thinking hard about what steps to take.  1 2 3 4 
26.  I’ve been blaming myself for things that happened.  1 2 3 4 
27. I’ve been praying or meditating.  1 2 3 4 
28.  I've been making fun of the situation.  1 2 3 4 
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APPENDIX J 
 
MEDICATION COMPLEXITY 
 
Please fill out the chart below regarding your current medications. If you need to, take a 
moment to get your medications if they are nearby to help you fill it out. If you need 
more room, continue listing the medications on this page.  
 
 
Drug name What is it for? (If unsure, 
write “I don’t know”) 
How often are you supposed to take 
this medicine? 
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APPENDIX K 
 
MEDICATION ADHERENCE MEASURE 
 
1. Do you sometimes forget to take your high blood pressure 
pills?  
Yes No 
2. Over the past 2 weeks, were there any days when you did not 
take your high blood pressure medicine?  
Yes No 
3. Have you ever cut back or stopped taking your medication 
without telling your doctor because you felt worse when you 
took it?  
Yes No 
4. When you travel or leave home, do you sometimes forget to 
bring along your medications?  
Yes No 
5. Did you take your high blood pressure medicine yesterday?  Yes No 
6. When you feel like your blood pressure is under control, do 
you sometimes stop taking your medicine?  
Yes No 
7. Taking medication everyday is a real inconvenience for some 
people. Do you ever feel hassled about sticking to your blood 
pressure treatment plan?  
Yes No 
8. Do you have difficulty remembering to take all your blood 
pressure medication?  
Yes No 
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APPENDIX L 
 
LIFESTYLE ADHERENCE MEASURE 
 
1. Did your doctor provide recommendations for diet and exercise?       Yes      No 
 If yes, what were those recommendations? 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
2. Has a healthcare professional (for example, a doctor or nurse) ever told you that you 
need to quit smoking because of your heart problems?        
Yes      No 
 
3. On average, how many days per week did you engage in a total of 30 minutes or more 
of: 
 Mild exercise (i.e., walking leisurely, stretching): ______ 
Moderate exercise (i.e., walking briskly, biking less than 10 mph, water 
aerobics):____ 
Vigorous exercise (i.e., jogging/running, aerobic dancing, swimming laps): ____ 
 
4. Do you keep track of how much salt you eat or drink?           Yes       No 
 
5. Do you keep track of how much fat you eat?                               Yes       No 
 
6. Do you make an effort to reduce how much sugar you eat?            Yes       No 
 
7. On average, how many alcoholic drinks do you consume per day? ______ 
 
8. On average, how many alcoholic drinks do you consumer per week? _____ 
 
9. On average, how many times per week do you eat fish?  _______  
 
10. On average, how many servings of fruits and vegetables do you eat per day (1 
serving = ½ cup)? _______ 
 
11. On average, how many servings of whole grains do you eat per day (1 serving = ½ 
cup whole grain pasta, oatmeal, brown rice or other grain, or 1 slice of bread)?   
________   
 
12. When eating out at restaurants, do you try to choose foods that go along with your 
doctor’s recommendations?                  
Yes      No 
 
 
 
